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Abstract

A MOLECULAR MECHANISM REGULATING THE TIMING OF
CORTICOGENICULATE INNERVATION
By Justin McRae Brooks, B.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.

Virginia Commonwealth University, 2013

Michael A. Fox, PhD
VTCRI Associate Professor
Department of Biological Sciences

Visual system development requires the formation of precise circuitry in the dorsal
lateral geniculate nucleus (dLGN) of the thalamus. Although much work has examined
the molecular mechanisms by which retinal axons target and form synapses in dLGN,
much less is known about the mechanisms that coordinate the formation of non-retinal
inputs in dLGN. These non-retinal inputs represent ~90% of the terminals that form in
dLGN. Interestingly, recently reports show that the targeting and formation of retinal
and non-retinal inputs are temporally orchestrated. dLGN relay neurons are first
innervated by retinal axons, and it is only after retinogeniculate synapses form that
axons from cortical layer VI neurons are permitted to enter and arborize in dLGN. The
molecular mechanisms governing the spatiotemporal regulation of corticogeniculate
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innervation are unknown. Here we screened for potential cues in the perinatal dLGN
that might repel the premature invasion of corticogeniculate axons prior to the
establishment of retinogeniculate circuitry. We discovered aggrecan, an inhibitory
chondroitin sulfate proteoglycan (CSPG), was highly enriched in the perinatal dLGN,
and aggrecan protein levels dropped dramatically at ages corresponding to the entry of
corticogeniculate axons into the dLGN. In vitro assays demonstrated that aggrecan is
sufficient to repel axons from layer VI cortical neurons, and early degradation of
aggrecan, with chondroitinase ABC (chABC), promoted advanced corticogeniculate
innervation in vivo. These results support the notion that aggrecan is necessary for
preventing premature innervation of the dLGN by corticogeniculate axons. To
understand the mechanisms that control aggrecan distribution, we identified a family of
extracellular enzymes (the a disintegrin and metalloproteinase with thromobospondin
motifs [ADAMTS] family) expressed in postnatal dLGN that are known to contain
aggrecan-degrading activity. Importantly, ADAMTS family members are upregulated in
dLGN after retinogeniculate synapses form, and intrathalamic injection of ADAMTS4
(also known as aggrecanase-1) resulted in premature invasion of dLGN by
corticogeniculate axons. Taken together these results implicate aggrecan and
ADAMTSs in the spatial and temporal regulation of non-retinal inputs to the dLGN.
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Chapter I
Introduction to Axon Guidance, Extracellular Matrix, and Visual
System Development
A Brief History of Neuron Doctrine
The central nervous system (CNS) is composed of neurons, glial cells, and
extracellular matrix molecules that perform crucial roles in the establishment of specific
neural circuits. The earliest knowledge regarding CNS circuitry was developed using
tissue staining techniques that were unable to fully resolve the cellular makeup of the
CNS and contained many artifacts. The reticular theory which postulated that the CNS
was composed of a continuous meshwork of cells and processes that were all
interconnected was prevalent during the pioneering days of neuroscience. Camillo
Golgi, however, revolutionized neuroscience through his invention of metallic stains,
including the potassium dichromate-silver staining technique. This technique called,
the “Golgi stain,” was the first method capable of staining individual neurons and glial
cells in their entirety, and its advent led to the morphological characterization of neurons
and neuroglia as completely distinct cell types (Golgi, 1875). Despite Golgi’s
passionate advocacy of reticular theory, he was never able to fully describe how the
nerve network was established in vivo because the Golgi stain was limited in that it
labeled small percentages of multiple cell types in CNS, making it impossible for Golgi
to fully distinguish between neuron and glial processes.
Many of Golgi’s colleagues utilized his own methods to refute the reticular theory.
Santiago Ramon y Cajal employed the Golgi stain on many species to create detailed
drawings of the cells in CNS and the development of connectivity in spinal cord and
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brain. His ability to map the fine structures of neural circuitry helped solidify neuron
theory as an axiom of modern neuroscience. During this period the dendrite and axon
(terms coined by Wilhelm His and Albert Von Kolliker, respectively) were categorized as
distinct functional domains of the neuron. The proposition of the existence of synapses,
the small contact zones between neurons that allow for unidirectional conduction (by
Charles Sherrington) was another observation that shaped the central tenets of neuron
theory, although their existence could not be proven until the advent of the electron
microscope (Sherrington 1897; Sherrington, 1900; Palade and Palay, 1954).
Ramon y Cajal pushed the neuron theory as a basis for studying the CNS
through the declaration that the CNS is composed of individual discontinous cells called
neurons, which all contain a “fundamental membrane” that are extensions of the neuron
(Ramon y Cajal,1909). Ramon y Cajal and his student Pio del Rio Hortega introduced
gold chloride and ammoniacal silver carbonate stains which allowed for the identification
of multiple types of glial cells (Ramon y Cajal, 1913; Rio-Hortega, 1919). Through the
development of methods to readily distinguish differing cell types, focus could be shifted
to elucidating the mechanisms that drive neuron connectivity. Neuron theory eventually
became neuron doctrine and was composed of these observations: the neuron is the
structural and functional unit of the CNS, neurons are composed of dendrites, soma,
and axons which are fundamentally different, and conduction of nerve impulses is
directional (Shepherd, 1991).

Evidence For Specific Targeting of Neuronal Connections
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In 1890, Ramon y Cajal described the structure by which axons navigate in the
developing nervous system called the growth cone. He also postulated that growth
cones are “oriented by chemical stimulation, and move toward the secretion products
from certain cells” (Cajal, 1892). Outgrowth of nerve fibers was established in tissue
culture experiments using the neural crest from frog embryo (Harrison, 1907; 1910);
however, there was a gap in understanding the mechanisms that drive axonal target
specificity, in vivo. There was still much debate over whether axons initially extended
throughout the CNS, and then were eliminated by competition, or if specific guidance
factors drove axons to distinct targets.
Evidence for specificity in establishment of synaptic connections was
discovered through JN Langley’s experiments on the preganglionic fibers of the superior
cervical ganglion. Upon bisection of these fibers, Langley observed regeneration in the
preganglionic axons from differing spinal cord levels to the proper postganglionic
neuron. Since regenerating axons did not grow to all levels of spinal cord and then
refine, this observation led him to propose a chemotactic mechanism for axon guidance
(Langley, 1895).
Support for chemotactic mechanisms was exemplified in Roger Sperry’s
experimentation on the frog visual system, which led to the proposal of his chemoaffinity
hypothesis. Normally axons that originate from cells in dorsal retina project to ventral
tectum, and axons that come from ventral retina project to dorsal tectum (Kandel et al.,
2000). Other orderly projections include axons projecting from anterior retina to
posterior tectum, while posterior fibers extend to anterior tectum. These orientations
produce a retinal topographic (retinotopic) visual map, in which adjacent neurons in the
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retina project to neighboring neurons in the brain, thus allowing the frog to see a faithful
representation of the outside world (Purves et al, 2001).
To test the whether these topographic maps developed through random
outgrowth of axons that are competitively eliminated based on activity or if there were
specific connections from neurons in the retina to the optic tectum, Sperry detached the
frog eye, inverted its positioning, and waited for the reestablishment of neuronal
connections. An important feature of the amphibian nervous system is that severed
retinal ganglion cell (RGC) axons regenerate and reinnervate the tectum. By rotating
the retina by 180°, Sperry discovered that the frogs had inverted visual maps and that
the axons in these animals projected to the proper areas of tectum despite the retinal
repositioning. (Sperry, 1963). His work sparked the chemoaffinity hypothesis that
growing axons are guided by gradients of molecular signals, and their positioning is
directed by different concentrations of few signals. Sperry’s experiments provided
strong evidence to illustrate that the placement of axon processes into their respective
retinotopic positions occurs through interactions of axons with molecules in the
extracellular space.

Axon Guidance and Synaptic Targeting
In order for the sensory systems to distribute information to the correct relay and
processing areas, axon guidance and synaptic targeting cues are necessary to set up a
precise neural network. Axon guidance refers to the process by which growth cones
react with their environment to select a pathway in which they travel long distances to a
specific target nucleus within the nervous system (Goodman and Shatz, 1993). Axon
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guidance requires ligand-receptor interactions resulting from either short range (contactmediated) or long range secreted (diffusible) signals (Zipursky and Sanes, 2010).
Contact-mediated attraction and repulsion occur at guide post cells, which contain
ligands and transmembrane receptors that alter the axon’s trajectory as the growth cone
traverses its path and physically interacts with other cells. Secreted chemoattracant
molecules can act over long distances and form gradients that direct axons, with
complementary receptors, to specific brain regions, while secreted chemorepulsive
signals can also act from afar but cause an axon to retract, pause, or turn depending on
strength of signal [(Figure 1A) Chen and Cheng, 2009].
Molecular mechanisms that drive axon guidance can also regulate synapse
formation. After an axon has selected a cellular partner, synapses between cells must
communicate in order to form a functional connection (Figure 1B). The first step in
synapse formation is called target recognition, in which a growing axon makes a
rudimentary connection onto a postsynaptic cell or in some cases a specific region on
that postsynaptic cell. Following synaptic targeting, synaptic differentiation prompts the
organization of synaptic elements and establishment of reciprocal communication
between the two cells, allowing each to synthesize the proper machinery for setting up a
mature, fully functional synapse. Finally, mature synapses that have found suitable
partners stabilize, while any improper or weak connections that have begun forming are
retracted and allowed to search for a new postsynaptic partner (Fox and Umemori,
2006). Presynaptic terminals that are unable to communicate and assemble a synapse
are ultimately degraded.
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Extracellular Matrix Effects on Axon Pathfinding and Synaptic Development
The development of CNS circuitry requires precise spatial and temporal targeting
of axons to specific partners in the distinct brain nuclei. During axon guidance and
synaptic targeting, many different extracellular and molecular mechanisms drive the
formation of specific connections. Axon guidance mechanisms have rigorously been
studied in CNS since the proposal of the chemoaffinity hypothesis, and the advent of
modern technology including genetically altered mouse models, along with high
resolution imaging techniques, has advanced understanding of the biochemical
mechanisms that drive axon guidance and targeting.
Many molecular axon guidance cues that have been elucidated are functional in
differing areas of the CNS. Netrins are evolutionally conserved, diffusible molecules
that are secreted from cells at the midline of the spinal cord, and netrins can act either
as chemoattractant or chemorepulsive signals, depending on the type and density of
receptors expressed on the growth cone of an approaching axon (Tessier-Lavigne and
Goodman, 1996). Netrins and netrin receptors, such as DCC/Unc, contribute to the
guidance of thalamocortical axons to their proper targets in cortex (Powell et al., 2008).
Contact-mediated attraction and repulsion are also guided by expression of extracellular
molecules, but these are inititated by complementary receptors and ligands embedded
in the surfaces of cells encountered during axon outgrowth (Chen and Cheng, 2009;
Kolodkin and Tessier-Lavigne, 2011). Semaphorins are a canonical repulsive guidance
cue ligand which can either be diffusible or membrane-bound for contact-mediated
signaling. Plexin receptors represent the major class of semaphorin receptors, and
activation of these receptors can signal disassembly of growth cone cytoskeletal
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molecules and initiate synaptic targeting (Zhou et al., 2008).
These guidance signals also can interact in a myriad of ways such that multiple
cues can be processed in parallel, which is a mechanism by which the brain processes
individual components of a single stimulus simultaneously. Signaling can work through
addition or multiplication of stimuli together or through opposition of each other’s effects;
however, the interactions between guidance molecules often are more complex than
just simple summation of positive and negative signals (Raper and Mason, 2010;
Dudanova and Klein, 2013). One such example of this complexity occurs in
commissural neurons, which react to both netrin and slit. Axons are guided to the
midline by netrin and subsequently should be repelled by slit; however, repulsion by slit
is suppressed by Robo-3/Rig-1, a Robo receptor that diminishes the effect of slit, until
the midline is reached. During midline crossing, slit activation of the Robo receptor
alters function of the DCC receptor, rendering the netrin signaling ineffective (Sabatier
et al., 2004; Chen et al., 2008).
In addition to secreted molecules and membrane bound receptors and ligands,
there are classes of extracellular matrix (ECM) molecules that have also been shown to
guide axons during development and also during regeneration of injured axons in the
CNS. Of particular interest are the proteoglycans, a subset of extracellular
macromolecules that are expressed in CNS and provide a substrate for tethering link
proteins to cells (Morawski et al., 2012). Studies involving chondroitin sulfate
proteoglycans (CSPGs) during development and in the adult have revealed potent
inhibitory signaling on the neuronal growth cones of many cell types. CSPGs
expressed in the periphery of the retina are involved with both proper spatiotemporal
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expression of RGC differentiation and directing RGC axons outward to the optic cup
(Brittis et al., 1992).
CSPGs interact with many substrates in CNS including growth-promoting laminin
(McKeon et al., 1995). The effect of CSPG inhibition was attenuated when laminin was
coexpressed with CSPG, although the reaction for different cell types was dependent on
the ratio of laminin/CSPG (Snow and Letourneau, 1992; Snow et al., 1996). These
studies provided evidence that CSPGs have variable effects on diverse cell types.
CSPGs also interact with cell adhesion molecules (CAMs) to regulate axon outgrowth,
and evidence has shown that sensory neurons can overcome CSPG inhibition through
overexpression of integrin receptors (Condic et al., 1999; Tan et al., 2011). Moreover, a
recent in vivo study of serotonergic neurons suggests that increased expression of
either β1 integrin, growth-associated protein-43 (GAP-43), or a combination of the two
enables them to overcome CSPG inhibition in response to spinal cord injury (Hawthorne
et al., 2011). GAP-43 has also been implicated in enhancing axon growth after injury in
commissural interneurons of the cat spinal cord (Fenrich et al., 2007). Together, these
studies provide support for how a complex series of interactions between cells, ECM,
and growth substrates influence axon outgrowth.
Molecular factors also aid in synaptic targeting. Subcellular specificity dictates
where a presynaptic axon will form a synapse on postsynaptic dendrites, soma, or
axons, and this process can be mediated by extracellular guidance cues or
transmembrane receptors (Sanes and Yamagata, 2009). For example, proteoglycans
expressed in distinct locations aid in targeting the growth cone to motor neuron
synapses, so that synaptogenesis can begin (Sanes, 2003). Neurofascin, a CAM in the
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immunoglobulin superfamily, is present in a gradient in postsynaptic Purkinje cells of the
cerebellum. Presynaptic axons from basket cells first innervate the soma and proximal
dendrites of Purkinje cells and then work their way up the neurofascin gradient to their
final subcellular locations (Ango et al., 2004). CSPGs also have been reported to play
a role in mediating lamina-specific adhesion and lamina-specific axon outgrowth in the
dentate gyrus of the hippocampus by entorhinal cortical afferents (Forster et al., 2001).
During early development CSPGs are derived from neurons; however, as the
brain integrates circuitry from diverse sensory areas and more cells participate in the
maintenance and plasticity of synaptic function, CSPGs, other ECM, and guidance
factors are produced by neurons and non-neuronal “glial” cells including astroctytes,
oligodendrocytes, and microglia in the brain (Domowicz et al., 1996). This level of
complexity makes it difficult to ascertain the exact functions of individual cell types and
ECM in the adult CNS. Astrocytes and microglia produce thrombospondins,
extracellular proteases, and growth factors that potentially could alter the routing of
axons (Dityatev et al., 2010; Crawford et al.,2012; Frischknecht and Gundelfinger,
2012).

Development of The Visual System from Retina to Brain
The visual system serves as an excellent model for understanding the formation
of neural circuits because of its accessibility, anatomy, and role in sensory processing.
The development of the visual system has been well characterized, and much of the
formation of visual circuitry in the mouse occurs during the first two weeks of postnatal
life. The eye is an easily accessible structure for experimental manipulations, and
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RGCs provide the sole output from the retina to a plethora of retinorecipient nuclei in the
brain. The retinofugal (RF) system, in particular, provides a wealth of knowledge about
how RGC axons from the outer limits of the CNS can project long distances, innervate
subcortical brain regions, and stop within specific, functionally distinct nuclei to begin
synaptogenesis.
RGC extension is the first step in axon pathfinding. Until recently, factors
responsible for initiating axon outgrowth have remained elusive due to the inability to
examine growth, in vitro or in vivo, in the absence of neurotrophic factors because
neurons die (Goldberg and Barres, 2000). In order to better understand whether
intrinsic or extrinsic mechanisms drive axon outgrowth, a mouse model was developed
that overexpressed Bcl-2 anti-apoptotic factors, and RGCs were purified and grown in
the absence of glial contact (Goldberg and Barres, 2000; Goldberg et al., 2002). Under
these conditions, cells were able to survive without trophic factors, but there was no
axon outgrowth. Other previously published data on sensory neurons has shown
similar findings (Lindsay, 1988; Lentz et al., 1999). The next step was clearly defining
the extrinsic factors that could cause outgrowth. Many factors from a wide range of
families, including brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor
(CNTF), and oncomodulin, stimulate axon growth both in vitro and in vivo (Goldberg et
al., 2002; Yin et al., 2006).
Axons, once extended from the ganglion cell layer (GCL) in the retina, grow into
the optic fiber layer (OFL), and they must navigate away from the periphery towards the
optic disc and out of the eye. RGC axonal extension towards the optic cup occurs from
embryonic day 11 (E11) to E18 (Drager, 1985). These axons are restricted to the OFL
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by a layer of neuroepithelium located just inner to the OFL. The complexities of axonal
pathfinding begin at this particular step, as RGC axons that originate from different
areas of the retina begin to find their way out. Axons that project ipsilateral, or to the
same side of the brain as the eye, originate in the ventrotemporal (VT) crescent of
retina, while fibers that project contralateral, or to the opposite side of the brain from the
eye, will come from all areas of the retina. These projections do not use the same
signaling mechanisms to target CNS nuclei. For example, neuroepithelial endfeet
strongly express neural cell adhesion molecules (NCAMs) in rats, like L1-CAM (L1),
which allows extension of some pioneer RGC fibers (Brittis and Silver, 1995; Brittis et
al., 1995). Axons that follow pioneer RGCs use a different set of molecules to
fasciculate and travel with the pioneer axons.
Synaptic targeting requires more than molecular cues to locate distinct cellular
partners. The retina also produces spontaneous retinal waves before eye opening at
postnatal day 14 (P14) that govern expression of molecular signals and alter the final
pattern of innervation within thalamic targets (Chalupa, 2007; Rebsam et al., 2009).
Stage 2 waves are the most relevant to the experiments included in this dissertation,
and they begin around P0 in mice and last until approximately P10. Stage 2 retinal
waves arrive coincident with retinotopic mapping in the CNS, and the waves allow for
pruning of weak synapses and the differentiation and maturation of proper synaptic
contacts. Retinal waves also help pattern eye specific segregation. These stage 2
waves are generated by starburst amacrine cells, and driven by acetylcholine release
from these cells (Feller et al., 1996). They occur relatively infrequently at a rate of one
every 1-2 minutes. This frequency was determined to be a driving factor for the eye
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specific segregation between projections within the CNS because of the high probability
that they would be sending information at alternating times, as opposed to simultaneous
transmission (Butts et al. 2007).
Anterograde tracers, utilized long before transgenic mice, allowed insight to the
timing of development of retinogeniculate (RG) and retincollicular (RC) projections
(Godement et al., 1984). As RGCs innervate their primary targets in subcortical CNS,
the complexity of visual circuit formation continues to build as relay neurons from
distinct thalamic nuclei project axons to other areas of brain including some projections
into primary visual cortex (V1) for higher order processing (Yamada et al.,1996; Van
Hooser, 2007; Huberman and Neill, 2011). V1 spreads information to other associated
areas of the cortex for further assimilation and processing of perception, as well as
feedback circuits to retinorecipient thalamic nuclei.
RGCs are divided into over 20 separate classes which encode information for
both image-forming and non-image-forming visual streams. ON-OFF selective RGCs
react to increases (ON) or decreases (OFF) in the amount of light presented to the
retina, direction selective RGCs respond to horizontal or vertical movement of an object,
and other RGCs respond to and transmit information regarding colors (Chalupa and
Gunhan, 2004; Demb et al., 2007; Kim et al., 2008; Quina et al., 2005; Schmidt et al.,
2011; Badea et al., 2009). These particular classes constitute a subset of the imageforming stream of visual data, and they target CNS nuclei in the thalamus that are
important for relaying information to areas of cortex that form perception of the visual
scene. Intrinsically photosensitive RGCs (ipRGCs) that contain the photopigment
melanopsin also occupy the GCL in the retina, and ipRGCs project primarily within the
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non-image forming pathway of visual data to distinct nuclei in the brain that encode
information regarding circadian rhythm and irradiance detection (Provencio et al., 2000;
Hattar et al., 2002; Hattar et al., 2006). These cell subtypes have become important for
understanding how specific guidance cues contribute to class-specific targeting,
especially since the project axons to closely apposed, distinct nuclei where differential
patterns of guidance cues can be identified and monitored.
Much research regarding RF circuitry in mice focuses on the lateral geniculate
nucleus (LGN), which is an important subcortical relay and processing visual center
located in the dorsal thalamus. In mice, the LGN contains three separate subnuclei
called the dorsal LGN (dLGN), intergeniculate leaflet (IGL), and the ventral LGN
(vLGN). The three LGN subnuclei have distinct functions, and they serve as a primary
relay center from the retina to other subcortical areas, and, in the case of dLGN, a relay
center from retina to V1. Certain image-forming RGC axons will target and primarily
innervate the dLGN, while ipRGCs will advance directly to the IGL and vLGN [Figure 2.
(Hattar et al., 2006; Kay et al., 2011; Fox and Guido, 2011)].
The timing of RG innervation is stereotypical with pioneer axons innervating the
dLGN at E16 (Godement et al., 1984). Advances in anterograde labeling allow for
examination of projections from each eye converging or diverging within retino-recipient
nuclei. Intraocular injection of cholera-toxin subunit B (CTB) can be used to label retinal
projections from each eye [Figure 3. (Muir-Robinson et al., 2002; Jaubert-Miazza et al.,
2005)]. This allows visualization of eye specific domains in dLGN (Figure 3). During
postnatal visual development, axons from the retina form many synaptic contacts onto
relay neurons in dLGN. Initially, the small terminals of these weak synaptic contacts
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can be labeled with vesicular glutamate transporter type-2 (VGlutT-2) antibody
beginning at P3. VGluT-2 labeling of these synapses also provides insight into the
timing of differentiation and maturation of RGC terminals in dLGN as the terminals
increase in size until P14. These methods provide evidence that retinal terminals
compete for synaptic space, mature and refine during the period of development from
P4 until eye opening at P14 [Figure 3, (Guido, 2008)].
Eye-specific refinement of the retinal axons was shown in dLGN beginning
around P4 when projections from each eye do not have clear borders (Guido, 2008). At
P7, the axon terminals show signs of segregation, but it is not until P14, when eye
opening occurs, that each eye occupies clear domain with little or no overlap between
the ipsilateral and contralateral projections (Jaubert-Miazza et al., 2005). Retinal
waves, a form of spontaneous retina-based activity, have been reported as major
contributors to segregation of retinal axons.

In addition to retinal activity, the

expression profile of certain ephrins and Eph receptors have been shown to drive retinal
axon refinement into eye-specific domains [Figure 3. (Pfeiffenberger et al., 2005;
Rebsam et al., 2009; Sanes and Zipursky, 2010; Triplett and Feldheim, 2011)]. Recent
evidence indicate that ipRGCs, which express melanopsin, the only functional opsin in
the retina at birth, react to light and modulate stage 2 retinal waves and contribute to
retinal refinement (Renna et al., 2011; Kirkby and Feller; 2013).
In addition to eye specific domains, retinal projections also target specific nuclei
topographically, so that neurons that are adjacent in the retina project axons to
neighboring neurons in retino-recipient nuclei (Luo and Flanagan, 2007). Utilizing
transgenic reporter mice that label only individual classes of RGCs and mutant mice
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lacking targeting molecules, multiple visual system targeting mechanisms have been
well characterized; for example, gradients of ephrins and Eph receptor help arrange
RGC axons in dLGN and superior colliculus (SC) (Feldheim et al., 1998; Hindges et al.,
2002; Huberman et al., 2008). Retinal input instructs alignment of topographic maps
from V1 and retina in the SC, such that corticocollicular mapping happens after
retinocollicular mapping, and retinal input is required for precise mapping and
corticocollicular fiber refinement (Triplett et al., 2009). Alignment of topographic maps is
deemed necessary for proper visual perception, and this study also revealed the
importance retinal activity on non-retinal (ie V1) inputs to retinorecipient thalamic nuclei.
Though the thalamic nuclei were originally postulated to serve only as a relay for
sensory information travelling to the cortex, recent research suggests that the thalamic
nuclei serve much more dynamic roles, such as providing adjustments to retinal input
from feedback provided by layer VI cortical neurons (Cudeiro and Sillito, 2006).
Retinal activity and extracellular components can drive the specificity of
topographic maps and eye-specific domains within retinorecipient nuclei, but little is
known about the mechanisms that affect class-specific targeting to distinct nuclei. The
glycoprotein reelin has been shown to guide ipRGCs into the vLGN and IGL (Su et al.,
2011). In the absence of functional reelin ipRGC axons fail to innervate the vLGN and
IGL, and the ipRGC axons are misrouted to inappropriate thalamic nuclei. Mice that
lack Dab1 receptor, a molecule essential for reelin function (Sheldon et al., 1997), also
showed misrouting of projections, that usually terminated in vLGN and IGL, towards
dLGN (Su et al., 2011). These findings suggest that ECM may play a large part in the
axon guidance of both image-forming and non-image-forming pathways.
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Much of what has been learned regarding class-specific targeting in visual
system has focused only on circuitry between the retina and relay neurons in the
thalamus. Moving forward, application of what has been learned through these studies
will need to be applied to non-retinal inputs to LGN including axons from brainstem,
cortex, reticular thalamic nucleus (RTN) and interneurons which provide 90% of the
innervation in LGN and help process retinal signal as it proceeds to cortex.

Interconnectivity in the Thalamus
In addition to RG axons, there are numerous other cell types that innervate
dLGN. In fact, RG axons form less than 10 percent of the synapses onto relay neurons,
despite being the primary driver for producing synaptic responses in relay neurons (Van
Horn et al., 2000). The majority of non-retinal input to dLGN are glutamatergic
modulatory synapses that originate from layer VI cortical neurons in visual cortex (Erisir
et al, 1997; Jones 2002). Relay neurons are also innervated by local GABAergic
interneurons within the dLGN, inhibitory projection neurons from the RTN, and
modulatory projections from brainstem and SC (Sherman and Guillery, 2002; Bickford et
al., 2010). The development of these non-retinal inputs to the dLGN has not been well
characterized because of the difficulty in labeling particular classes of neurons in
confined areas of the CNS.
Recent advances in transgenic mouse reporter lines have enabled a more
developed study of non-retinal inputs to the dLGN. In particular, the golli-tau-gfp
mouse, which has layer VI cortical neurons and their projections selectively labeled with
green fluorescent protein (GFP), has aided the efficient visualization of how and when
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dLGN is innervated by axons from layer VI cortical neurons, also called
corticogeniculate (CG) axons (Jacobs et al., 2007; Grant et al., 2012). This reporter
mouse line provides an argument for class-specific targeting in cortex, as it is apparent
that particular layers of cortical neurons project fibers that innervate specific locations.
Layer VI axons have been shown to selectively innervate dLGN, while projections from
layer V pyramidal cells also project to the LGN but terminate in vLGN/IGL areas [Figure
4. (Cosenza and Moore, 1984; Jacobs et al., 2007)].
Spatial organization of RG and non-retinal inputs onto distinct relay neurons is
important in the formation of neural circuitry. Retinotopic maps begin formation in the
LGN prior to afferents from the cortex, RTN, brainstem and interneurons (Bickford et al.,
2010). The non-retinal synapses have been reported to provide feed-forward,
feedback, and modulatory signals that alter the main stimulus coming from the retina,
and they presumably must connect onto relay neurons in register with the correct retinal
inputs for faithful image processing and correct behavioral outcomes (Sherman, 2012).
Subcellular specificity is also determined as the visual circuits begin to form
during the first week of postnatal life. Excitatory retinal synapses form on proximal
dendrites in order to drive action potentials. Inhibitory inputs from local interneurons will
receive input from RGCs and form synaptic contacts in close proximity to the RGC /
relay neuron interface to help tune the signal provided (Sherman and Guillery, 2002).
As mentioned previously, CG synapses form more synapses onto relay neurons, but
they innervate distal positions of the dendrites for the production of feedback signaling
(Figure 5).
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The spatial organization of retinal and non-retinal synapses may be connected
with the timing of their entry into dLGN. During dLGN development, RG axons are the
first projections to enter the dLGN, and they can synapse onto any area of relay neuron
that is available. RG fibers form synaptic contacts onto proximal dendrites of the relay
neurons, but it is unclear whether they occupy that particular area because of affinity,
because they are the first projections to arrive, or because of a combination of affinity
and timing (Sherman and Guillery, 2002).
The timing of CG innervation follows that of RG fibers; importantly, RG fibers
begin synaptic differentiation immediately prior to the beginning of layer VI CG axon
entry into dLGN (Figure 6). Though CG axons begin to invade dLGN at P4, synaptic
contacts marked by vesicular glutamate transporter-1 (VGluT-1) do not begin to appear
in the dLGN until P7 [Figure 6, (Seabrook et al., 2013)].

Probing the Role of Retinal Activity and Molecular Guidance on Layer VI Cortical
Projections to dLGN
Recent studies using the golli-tau-gfp mouse have demonstrated that retinal
inputs may play an instructive role in regulating the timing of CG innervation.
Specifically, RG axons begin synaptic remodeling in dLGN prior to CG fiber entry, and
removal of retinal input by enucleation or genetic ablation accelerates layer VI cortical
innervation in dLGN (Seabrook et al., 2013). This suggests that retinal input to dLGN
may be providing a stop signal that inhibits non-retinal innervation of dLGN until RG
synapses have begun to function.

19

In light of this work, the goal of my project was to discover the molecular
mechanisms that regulate the timing of CG axon innervation. As mentioned previously,
there must be a balance of activity and guidance factors working to provide the perfect
environment for proper synapses to form; however, little is known about molecular
mechanisms that guide non-retinal inputs in the thalamus. Here I report that the
inhibitory CSPG, aggrecan, is robustly expressed in the dLGN during early visual circuit
formation. I sought to classify its function and regulation during this phase of
development. Based on the preliminary data and the coincident delay of CG innervation
of the dLGN, I hypothesized that aggrecan initially repels layer VI cortical projections
from entering dLGN until proper synapses form between RGCs and relay neurons in the
dLGN.
Little is known regarding mechanisms that drive how and when the CG afferents
invade dLGN, but my studies support a novel role for aggrecan in the timing of layer VI
CG innervation. Not only have I established a new role for aggrecan, but I also provide
evidence detailing the cascade of events that mediate aggrecan distribution in postnatal
dLGN. My results indicate that retinal inputs alter relay neuron expression of
aggrecanases. Taken together, these experiments describe the dynamic interplay of
retinal activity and molecular signaling in the establishment of layer VI innervation in
dLGN.
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Figure 1: Axon guidance in the CNS. (A) The blue cell projects a growth cone that
responds to different extracellular cues to grow an axon to the appropriate target area.
Cells secreting chemospecific attractive molecules (green) drive the initial direction of
axon outgrowth. A guidepost cell, which contains inhibitory contact-mediated cues,
causes the growth cone to turn, while complementary attractive and inhibitory
chemospecific guidance cues push and pull the growth cone to its final target area. (B)
Inhibitory cues cause the growth cone to avoid the red cell completely and search for
more appropriate targets. Attractive chemospecific cues allow the growth cone to
extend towards the dendrites located on the black cell, where the first steps of
synaptogenesis can begin. The green cell may contain attractive elements within its
dendrites, but it has not been targeted by the growth cone due to a lack of extracellular
cues. Many of the same molecules that drive axon guidance over long distances can
also guide the axons toward specific cells.
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Figure 2: Class-Specific RG Targeting in LGN. RGCs project axons long distances and
innervate visual nuclei in the brain. Different classes of RGCs project to distinct retinorecipient nuclei in LGN. For example, image-forming classes of RGCs (green) project
to dLGN, whereas non-image forming classes of RGCs innervate vLGN and IGL.
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Figure 3: Eye-specific segregation and maturation of retinal terminals during the first
two weeks of postnatal visual development. Top panel: CTB, conjugated to Alexa-fluor
594 (red), labels contralateral retinal axons in dLGN, and CTB, conjugated to alexa-fluor
488 (green) labels retinal axons from the ipsilateral eye. The images illustrate dLGN
innervation by retinal axons from each eye at P3, P7, P10, and P14. Bottom Panel:
Immunostaining with VGlutT-2 shows the maturation of retinal synapses from
synaptogenesis at P3 until maturation at P14. Scale bar is 250 µm.
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Figure 4: Class-Specific CG Targeting in LGN. Cortical neurons are separated into
distinct laminae, much like retinal reurons (Figure 2). Neurons in layers V and layer VI
of cortex project axons to nuclei within the thalamus. In LGN, axons from layer V
pyramidal cells (red) target vLGN, while axons from layer VI project to dLGN.
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Figure 5: Schematic depicting the subcellular distribution of inputs onto relay neurons in
dLGN. Retinal inputs (grey) are the primary drivers of relay neurons in dLGN and are
located on proximal dendrites of relay neurons. Inhibitory and modulatory synapses
from interneurons (Red) and brainstem (Blue), respectively, occupy proximal positions
on dendrites and typically provide more inputs than RGCs. Inhibitory interneurons are
also innervated by retinal axons to provide modulatory feed-forward inhibition of the
signal. Inhibitory synapses from RTN (Purple) axons are positioned distal to RGC,
interneuron, and brainstem projections. Feedback input from layer VI cortical axons are
also numerous, but they generally are located on the distal dendrites of relay neurons.
[(+) denotes excitatory glutamatergic inputs, (-) denotes inhibitory GABAergic inputs,
and (m) denotes modulatory acetylcholinergic input].
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Figure 6: CG innervation and synapse labeling during the first two weeks of postnatal
development. Top Panel: GFP-immunoreactivity (IR) in the golli-tau-gfp mouse reveals
the timing of layer VI cortical fiber innervation in dLGN from P3 – P14. Bottom Panel:
Immunostaining using VGlut-1 reveals the timing of synapse development between
layer VI CG axons and relay cells. Scale bar is 250 µm.
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Chapter II
Experimental Methods

Mice
CD1 and C57/BL6 wild-type mice were purchased from Charles River
(Wilmington, MA) or Harlan (Indianapolis, IN). acancmd heterozygous mice which lack
functional aggrecan, were purchased from The Jackson Laboratory (Bar Harbor, ME).
The generation of math5-/- and golli-tau-gfp mice were described previously (Wang et
al., 2001; Jacobs et al., 2007). Genomic DNA was isolated from tails using the
HotSHOT method as previously described (Truett et al., 2000; Su et al. 2010) and
genotyping was performed with the following primers purchased from Integrated DNA
Technologies (Coralville, Iowa): math5, ATG GCG CTC AGC TAC ATC AT and GGG
TCT ACC TGG AGC CTA GC; neomycin (neo), GCC GGC CAC AGT CGA TGA ATC
and CAT TGA ACA AGA TGG ATT GCA; gfp, AAG TTC ATC TGC ACC ACC G and
TCC TTG AAG AAG ATG GTG CG; cmd, CCA TCT CCT CAG CGA AGC AG and CTA
CAA GGA CAG TGA CTT TG. The following conditions were used for genotyping:
math5, 35 cycles using a denaturation temperature of 94ºC for 30 seconds, annealing at
59ºC for 30 seconds, and elongation at 72ºC for 45 seconds; neo, 35 cycles using a
denaturation temperature of 94ºC for 30 seconds, annealing at 56ºC for 30 seconds,
and elongation at 72ºC for 45 seconds; gfp, 35 cycles using a denaturation temperature
of 94ºC for 30 seconds, annealing at 55ºC for one minute, and elongation at 72ºC for
one minute; acancmd, 32 cycles using a denaturation temperature of 94ºC for 15
seconds, annealing at 58ºC for 20 seconds, and elongation at 72ºC for one minute.
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Further treatment of acancmd polymerase chain reaction (PCR) products using BpmI
restriction endonuclease (New England Biolabs, Ipswich, MA) was performed according
to previous reports (Watanabe et al, 1997). All analyses conformed to National
Institutes of Health guidelines and protocols approved by the Virginia Polytechnic
Institute and State University and Virginia Commonwealth University Institutional Animal
Care and Use Committees.

Antibodies
The following antibodies were purchased: mouse anti-phosphacan (3F8)
(Developmental Studies Hybridoma Bank, University of Iowa; 1:100 dilution); rabbit antiGFP (Invitrogen, Grand Island, NY; 1:250 dilution), mouse anti-chondroitin sulfate
proteoglycan protein core epitope (cat315) (Chemicon, Temecula, CA; 1:2000 dilution),
anti-mouse/rat neurocan (R&D systems, Minneapolis, MN; 1:50 dilution), rabbit antimouse versican (GAG alpha domain) polyclonal antibody (Millipore, Billerica, MA; 1:500
dilution), mouse anti-brevican (BD Biosciences, San Jose, CA; 1:500 dilution), rabbit
anti-VGluT-1 (Synaptic Systems, Goettingen, Germany; 1:500 dilution), rabbit antiVGluT-2 (Synaptic Systems, 1:500 dilution), rabbit anti-glial fibrillary acidic protein
(GFAP; DAKO, Carpinteria, CA; 1:2500 dilution), rabbit anti-ionizing calcium-binding
adaptor 1 (Iba-1; WAKO, Richmond, VA; 1:500 dilution), monoclonal mouse antineuronal nuclei (NeuN; Chemicon 1:200 dilution). Fluorescently conjugated secondary
antibodies were purchased from Invtirogen (1:1000 dilution).

Immunohistochemistry (IHC)
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IHC was performed as previously described (Su et al. 2010, 2011). After mice
were transcardially perfused with phosphate-buffered saline (PBS; pH 7.4) and 4%
paraformaldehyde in PBS (PFA; pH 7.4), brains were removed and post-fixed in PFA for
12 hours at 4°C. Brains were cryopreserved in 30% sucrose solution for 24 hours,
embedded in Tissue Freezing Medium (Electron Microscopy Sciences, Hatfield, PA),
and cryosectioned (16–20 µm coronal sections). Sections were air-dried onto
Superfrost Plus slides (Fisher Scientific, Pittsburgh, PA) before incubating in blocking
buffer [2.5% bovine serum albumin (BSA), 5% Normal Goat Serum (NGS, 0.1% TritonX in PBS for at least 30 minutes]. Primary antibodies were diluted in blocking buffer and
incubated on the tissue sections for >12 hours at 4°C. After washing in PBS,
fluorescently conjugated secondary antibodies diluted 1:1000 in blocking buffer were
incubated on sections for 1 hour at room temperature. After thorough washing in PBS,
sections were stained with 4',6-diamidino-2-phenylindole [(DAPI) 1:10,000 in water] and
were mounted with Vectashield (Vector Laboratories, Burlingame, CA). For versicanIHC, tissue sections were digested with chondroitinase ABC (chABC; 0.01U/ml in
blocking buffer [Sigma, St Louis, MO]) for >30 minutes at 37°C prior to incubating with
blocking buffer. Images were acquired on a Zeiss AxioImager A2 fluorescent
microscope, a Zeiss Examiner Z1 LSM710 confocal microscope or a Zeiss LSM 700
confocal microscope. When comparing different ages of tissues or between genotypes,
images were acquired with identical parameters. A minimum of three animals (per
genotype and per age) were compared in all IHC experiments. Spatial coverage of
dLGN by aggrecan and GFP-labeled layer VI fibers was examined using threshold
analysis as described previously (Jaubert-Miazza et al., 2005). Briefly, acquired images
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were cropped after background fluorescence was subtracted and grayscale images
were normalized using Adobe Photoshop. dLGN was encircled and isolated from optic
tract, vLGN/IGL and medial thalamus. The image was then binarized using a threshold
value of 50 in order to distinguish signal from background fluorescence. Total pixels in
dLGN were calculated, as were the total number of pixels representing fluorescent
signal (Jaubert-Miazza et al., 2005). Area of coverage was calculated by dividing signal
area/total area of dLGN in 3-4 dLGN samples representing the middle of the dLGN.
Plot profiles were obtained using imageJ software. Images were imported into imageJ
software and a line scan was analyzed using the plot profile command. Data was
exported into Microsoft excel where displacement distances were converted to µm.
Fluorescent intensities represent averages for every three pixels (1.8 µm) for each
image over the first 50 µm displacement into dLGN, and data was plotted in a line graph
for images collected from n≥3 animals.

Dissociated Cortical Cultures
Cerebral cortices were dissected from E15-E18 golli-tau-gfp embryos and were
digested in 0.25% trypsin at 37°C for 15 min. Following digestion, soybean trypsin
inhibitor was used to inactivate trypsin and cortical tissue was transferred to serum-free
medium (Neurobasal medium with 0.5mM L-Glutamine, 25 uM L-Glutamate, 10ug/ml
Gentamicin with B27 supplement). A single cell suspension was generated by triturating
tissues through a 1000ul pipette tip and 5x103 cells were added to each well of a poly-Llysine (PLL) treated 8-well lab-Tek chamber slide. In addition to being pre-treated with
PLL, chamber slides were “spotted” with various extracellular substrates to assess
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neurite outgrowth. Briefly, various concentrations (1 µg/ml, 5 µg/ml and 10 µg/ml) of
aggrecan (Sigma), chABC or recombinant human A Disintegrin and Metalloproteinase
with Thrombospondin Motifs- type-4 (rhADAMTS4, R&D Systems) were mixed with BSA
conjugated to Alexa-Fluor 594 (Invitrogen) (2 µg/ml) and 2µl spots were placed onto the
slide surface in separate chambers and allowed to incubate in a humidified chamber at
37 °C for two hours. The ability of chABC or rhADAMTS4 to degrade aggrecan was
assessed by pre-incubating 10 µg/ml aggrecan with 50U/ml chABC in PBS or 10 µg/ml
rhADAMTS4 before mixing with BSA- Alexa-Fluor 594. After plating, cortical neurons
were cultured for 3 days at 37°C in 5% CO2 before being fixed with 4% PFA (in PBS)
and imaged. Layer VI neurons (and their neurites) were immunolabeled with anti-GFP
antibodies and I counted the numbers of neurons whose neurites were able to grow into
the “spotted” substrates. Only neurites from cell bodies that lie within 50 µm of the spot
of interest were counted. A minimum of four experiments (each with at least 3
replicates) was compared in all in vitro experiments.

Fluorescent In Situ Hybridization (FISH)
FISH was performed on 16–20 µm cryosectioned coronal sections as described
previously (Su et al. 2010, 2011). Sense and anti-sense riboprobes were generated
against syt1, adamts4 and adamts15 (Image Clone ID syt1: 5363062; adamts4:
5345809; adamts15: 30619053; Open Biosystems, Huntsville, AL). Riboprobes were
synthesized using digoxigenin- (DIG) or fluorescein-labeled uridylyltransferase (UTP)
(Roche, Mannheim, Germany) and the MAXIscript in vitro Transcription Kit (Ambion,
Austin, TX). Riboprobes were hydrolyzed into ~0.5 kb fragments. Coronal brain
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sections were prepared and hybridized as described previously (Yamagata et al. 2002;
Fox and Sanes 2007). Bound riboprobes were detected by horseradish peroxidase
(POD)-conjugated anti-DIG antibodies and fluorescent staining with Tyramide Signal
Amplification (TSA) systems (PerkinElmer, Shelton, CT). For double FISH (D-FISH),
after the first TSA reaction sections were washed in Tris-buffered saline (TBS),
incubated in 0.3% H2O2 for 30 min, and reacted with the second POD-conjugated
antibody. Images were obtained on a Zeiss AxioImager A2 fluorescent microscope or a
Zeiss Examiner Z1 LSM710 confocal microscope. A minimum of three animals per
genotype and age was compared in FISH experiments.

RNA isolation, Microarray, and quantitative Real-Time Polymerase Chain Reaction
(qPCR)
LGN subnuclei were isolated from P3 and P8 vLGN and IGL (vLGN/IGL) or
dLGN. Mice were decapitated, brains were removed and 400 µm coronal sections were
cut in ice-cold diethylpyrocarbonate-treated PBS (DEPC-PBS) with a vibratome.
vLGN/IGL or dLGN were micro-dissected and tissues from at least 5 littermates were
pooled per sample. RNA was isolated using the BioRad Total RNA Extraction from
Fibrous and Fatty Tissue kit (BioRad, Hercules, CA). For microarray analysis, RNA
purity assessment, first and second strand cDNAs preparation, cRNAs generation,
hybridization to Agilent Whole Genome 44k×4 mouse arrays, and data analysis with
Agilent Feature extraction and GeneSpring GX v7.3.1 software packages were
performed by GenUs Biosystems (Northbrook, IL). To be considered differentially
expressed genes must have been 2-fold higher in the averaged sample sets (n=3,
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p<0.05). 3 samples were analyzed per region. For qPCR, RNA was purified from pooled
samples isolated from P2, P3, and P7 in both math5-/- and golli-tau-gfp vLGN/IGL or
dLGN as described above. cDNAs were generated with Superscript II Reverse
Transcriptase First Strand cDNA Synthesis kit (Invitrogen, La Jolla, CA). qPCR was
performed on a Chromo 4 Four Color Real-time system (BioRad) using iQ SYBRGreen
Supermix (BioRad) as described previously (Su et al. 2010) or the Step One Plus RealTime PCR System (Applied Biosystems) was used with the GoTaq qPCR Master Mix
(Promega). The following primer pairs were used: actin, TTC TTT GCA GCT CCT TCG
TT and ATG GAG GGG AAT ACA GCC C; acan, CCC TCA GAG TCA CAA AGA CCA
and TTC GCA GGG ATA AAG GAC TG; adamts4, GTC ATG GCT CCT GTC ATG G
and CCG GTT TGT CTA AGA GGC AG; adamts8, ATC ACC GTG AGG ATG TGG TT
and CAA GAG GTT TGT GTC CGA GG, adamts9, TGT GGT GTT GGA GTG ATG
CAG AGA and TCT GGC TTC AGA TCA GTG TGG CAT; adamts15, ACA CTG CCA
TCC TCT TCA CC and TCT TGG GGT CAC ACA TGG TA; adamts19, CCT CTT TCA
GCA CCT GTG GA and GTG CGG GTG ACC TAT GAT G; gapdh, CGT CCC GTA
GAC AAA ATG GT and TTG ATG GCA ACA ATC TCC AC; lhx9, TCT TGC AAG GGG
AAT ATC CA and GTG CCA GTG CCA TTG AAG TA; dlx1, CTT AGC TCT GCC TGA
GAG GG and ACT TGG AGC GTT TGT TCT GG. The following cycling conditions were
used with 20 ng of RNA: 95°C for 15 minutes, followed by 40 cycles of amplification
(94°C for 15 seconds, 60°C for 20 seconds, 72°C for 20 seconds, read plate) and a
melting curve analysis on the on the Chromo 4 Four Color Real-time system. Step One
Plus Real-Time PCR System used a different program: 95°C for 2 minutes, followed by
40 cycles of amplification (95°C for 3 seconds, 60°C for 30 seconds, read plate) and a
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melting curve analysis. Relative quantities of RNA were determined using the ΔΔ-CT
method (Livak and Schmittgen, 2001). A minimum of n=3 experiments (each in
triplicate) was run for each gene, at each age examined and, to be considered
differentially expressed, genes must have been 2-fold higher in the averaged sample
sets (n=3, p<0.05). Each individual run included separate actin or Glyceraldehyde-3Phosphate Dehydrogenase (GAPDH) control reactions.

Intrathalamic Injections and Analysis of Corticogeniculate Spatial Innervation
P0-P1 golli-tau-gfp mice were anesthetized by hypothermia and injected
stereotactically through the skull using a glass pipette and the Picospritzer (5 msec at 8
PSI) with either 0.05 U/µl chABC (Sigma), 0.05 U/µl penicillinase [(PNase) Sigma] or 10
µg/mL rhADAMTS4 (R&D systems). Two injections, one near rostral dLGN (~3.7 mm
caudal to the olfactory bulb) and one near caudal dLGN (~4.7 mm caudal to the
olfactory bulb) were placed in dorsomedial thalamus ~1.0 mm from midline in order to
preserve cytoarchitecture and minimize trauma to dLGN. Two days post injection, mice
were euthanized, perfused, and tissue prepared for cryosections or vibratome. Spatial
extent of innervation by GFP labeled fibers was calculated using the threshold analysis
method described above.

Retinal Projection Labeling
Intraocular injection of CTB conjugated to Alex Fluor 488 or Alexa Fluor 594
(Invitrogen) was performed as described previously (Su et al. 2010). Briefly, mice were
anesthetized by hypothermia (<P7) or by isoflurane (>P7). The sclera was pierced with
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a glass pipette and excess vitreous humor was extracted. Another pipette containing
CTB (0.1 – 0.2%) was reinserted into the previous hole and CTB, using Picospritzer and
a prescribed volume (1-3 µl at P0-P10 and 3-5 µl for ages >P10) of solution, was
injected into the eye. After 1-2 days mice were killed, and brains fixed in 4% PFA
solution for 1 day, and brains were cryopreserved in 25% sucrose solution for 1 day. 16
µm coronal sections were cut using a cryostat or 40 um coronal sections were attained
using a vibratome. In mice that die perinatally or for posthumous retinal projection
labeling, the lens of the eye was opened and vitreous humor removed. Lipophilic DiI
[1,1’-dioctadecyl-3,3,3’,3’-tetramethylindocarbo-cyanine perchlorate (Sigma)] crystals
were placed into the cavity in close contact with the retina. The heads were submerged
in PFA and incubated at 37°C for ~6 weeks. Brains were prepared for coronal
sectioning using the vibratome. Images of DiI-labeled retinal projections to the brain
were taken on the same day as slides are prepared. Images were obtained on a Zeiss
AxioImager A2 fluorescent microscope or a Zeiss Examiner Z1 LSM710 confocal
microscope.
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Chapter III
Developmental Regulation of Aggrecan

Introduction

CG fibers comprise up to 50% of the innervation to relay neurons, constituting
one of the largest sources of input to the dLGN (Erisir et al, 1997; Jones, 2002).
Afferents from layer VI cells in visual cortex project directly to dLGN and help shape
signaling by relay neurons through tuning of receptive field properties and influencing
RG signal transmission (Sherman and Guillery, 2002). The mechanisms driving layer
VI cortical innervation of dLGN have been difficult to characterize due to the vast
number of synapses and lack of tools that distinguish between cell types; however, the
generation of the golli-tau-gfp transgenic reporter mouse line has improved the ability to
investigate early development of CG projections. In the golli-tau-gfp transgenic reporter
mouse, layer VI soma and processes are selectively labeled with a tau-GFP fusion
protein whose expression is driven by the golli promoter of the gene encoding myelin
basic protein (Landry et al., 1998; Xie et al., 2002).
Cortical projections, in these animals, traverse from the internal capsule and
begin invading the thalamus by P0. While these layer VI afferents innervate dorsal
thalamic nuclei immediately, the dLGN remains devoid of layer VI projections until P4
[Figure 6 (Jacobs et al., 2007; Grant et al., 2012)]. The timing of CG axon entry
coincides with the remodeling of retinal axons and appears to be orchestrated by RG
inputs (Seabrook et al. 2013). Due to the delay in CG innervation, I proposed a
mechanism by which extracellular guidance cues prevent premature innervation of
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dLGN by layer VI GFP-expressing axons, a process which appears to be regulated by
retinal inputs.

Identification of aggrecan localized in dLGN during cortical axon “waiting”
To identify guidance cues localized in dLGN, I initially profiled the transcriptome
of P3 and P8 dLGN, with the assumption that mRNA of repulsive cues inhibiting
premature CG innervation would be down-regulated as cortical axons began to enter
dLGN. No such molecules were identified (data not shown). As an alternative approach
I applied a candidate screen for CSPGs in neonatal dLGN. Many members of the
lectican family of CSPGs have been characterized as inhibitory to outgrowth of axons
(Kwok et al. 2008; Zimmerman and Dours-Zimmerman 2008); therefore, I sought to
determine the distribution of 5 prominent CNS CSPGs in LGN: brevican, neurocan,
versican, phosphacan and aggrecan.
Brevican, neurocan, versican, and phosphacan protein levels were detected at
low levels in LGN at P0, but each had a different expression pattern in the thalamus
(Figure 7). Brevican-IR was detected in areas dorsomedial to the dLGN, while
neurocan-IR was very low in dLGN. Plot profiles were obtained using line scans along
the vetrolateral-dorsomedial axis of LGN to examine the intensity of IR signal in each of
the three areas of LGN. Plot profiles measuring brevican and neurocan-IR in vLGN and
dLGN showed little signal, indicating presence of small amounts or no protein in these
areas. Versican-IR was present on the retinal axons in the optic tract and in tracts
traveling through the dLGN. The line scans of versican-IR indicated considerable signal
but little difference between levels in vLGN and dLGN. Phosphacan had an interesting
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pattern of IR, and it appeared graded from high levels of vLGN and IGL expression to
low levels in dLGN (Figure 7).
In contrast to other lecticans, aggrecan-IR was significantly elevated in the
neonatal dLGN and other areas of dorsal thalamus compared to both its own levels in
vLGN/IGL and the IR of the other CSPGs in the dLGN. Plot profiles illustrated the
magnitude of the aggrecan signal localized in dLGN compared to the low levels in the
vLGN (Figure 7).
Aggrecan is a bulky ECM proteoglycan composed of multiple functional domains.
The N-terminal globular domain (G1) can associate with other proteins to form large
aggregates of extracellular matrix, hence the name aggrecan. G1 is followed by an
interglobular domain (IGD). The chondroitin sulfate (CS) domain located towards the Cterminal end of the aggrecan molecule was considered the signaling domain (Figure 8).
The CS domain was discovered to be the repellant domain of functional aggrecan, and
specific CS-glycosaminoglycan (GAG) patterns have been reported to alter neurite
extension in vitro at levels comparable to intact aggrecan (Gilbert et al., 2005).
Combined with my initial aggrecan-IR results, these reports led me to investigate the
relationship between the timing of aggrecan expression in dLGN and the profile of CG
innervation.

Aggrecan expression during visual development
For my hypothesis to be correct, aggrecan distribution must be reduced either
through lower transcription, translation, or some other type of regulatory element as
layer VI cortical fibers begin to invade dLGN after P4. I conducted experiments to
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determine if acan mRNA transcription was diminished during the first postnatal week in
the golli-tau-gfp mouse dLGN by generating cDNAs for qPCR analysis from dissected
dLGN during development. The resulting pattern of expression from P2 to P14 was
contradictory to my hypothesis, indicating a steady increase in acan mRNA during
visual circuit formation; however, they were complementary to the general pattern of
acan mRNA expression the CNS (Figure 9A).
mRNA expression levels are not directly correlated to translation events or
protein levels, but there have been reports in the literature that, during development in
rodents, the antibody I used to specifically label aggrecan, cat315, also labels certain
isoforms of phosphacan (Dino et al., 2006). Thus, I was inclined to examine cat315
antibody specificity, especially after reviewing the qPCR data. First, the cat315
antibody did not label the phosphacan in the vLGN in my initial search for an inhibitory
guidance cue (Figure 7). Next, I tested the validity of my previous observations by
immunostaining embryonic sections of brain, using cat315, from the autosomal
recessive mouse mutant that lacks functional aggrecan, called the acancmd mouse
(Watanabe et al., 1994). Aggrecan-IR was abolished in the brains of these mice, and
these results confirmed that IR observed in the WT (wild type) dLGN at P0 is unique to
aggrecan (Figure 9B inset).
After I ensured the specificity of cat315 binding to aggrecan, I probed dLGN with
cat315 later during development, when axons from the layer VI GFP-labeled cortical
fibers in the golli-tau-gfp mouse were beginning to invade dLGN, to determine if
aggrecan was still present. My results showed that aggrecan was degraded throughout
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the dLGN by the time that CG projections spanned the entire dLGN and VGLuT-1
labeled cortical synapses began to appear (Figure 9B; Figure 6).

Aggrecan signal degraded prior to CG fiber entry into dLGN
Aggrecan’s structure has been well established, and its functions regarding
plasticity and regeneration in the CNS have been characterized, but the role of
aggrecan during visual circuit formation was unknown. As I performed a daily analysis
of CG innervation and aggrecan, from P0 when axons began to arrive at dLGN until P7
when axons occupy nearly 50% of dLGN, I began to uncover an important
developmental role for aggrecan in the orchestration of RG and CG circuitry using the
golli-tau-gfp mouse line. At P0 when aggrecan-IR was most intense, pioneer CG axons
began to enter vental thalamus from the internal capsule, and they started to climb the
external medullary lamina (eml) toward dLGN. However, they appeared to pause and
wait in eml just medial to the dLGN, and, for several days, they innervated other nuclei
of dorsal thalamus but not dLGN (Figure 10).
Aggrecan-IR covered the entire extracellular area of dLGN until P1 when the IR
signal appeared graded with aggrecan loss beginning at the ventromedial border of
dLGN and proceeding laterally. CG axons coincidentally remained outside of dLGN
during the period of time when aggrecan-IR was high, and CG fiber innervation was
inversely-correlated with the area occupied by aggrecan. Furthermore, CG fibers only
innervated the portions of dLGN at P4 where aggrecan-IR was nearly undetectable,
which led me to hypothesize that aggrecan regulates the timing of layer VI cortical axon
innervation in dLGN (Figure 10).
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Potential Role for retinal input in the regulation of aggrecan
A recent report analyzed the effects of retinal input on the timing of CG
innervation in dLGN, using the math5-/- mutant mouse line, which lacks 95% of RGCs
(Seabrook et al., 2013). That study also included binocular enucleation as a method for
destroying retinal inputs, and their observations led to the declaration that removal of
retinal inputs accelerates CG innervation. In order to confirm the lack of retinal
innervation in dLGN of math5-/- mutants, I used DiI, a lipophilic tracer, to label RGCs
and their afferents in different aged animals. WT mice exhibited distinct labeling in the
brain where retinal processes were located, but the math5-/- mutants contained no DiI
labeling at any age, suggesting that retinal input to the brain was completely absent
(Figure 11). By crossbreeding the math5-/- mutants to the golli-tau-gfp reporter mice, I
was able to probe the hypothesis that aggrecan protein must be significantly reduced by
the removal of retinal input to dLGN at perinatal ages in order for layer VI fibers to
exhibit accelerated entry into dLGN.
I analyzed the spatiotemporal distribution of aggrecan by examining IR in the
math5-/- mouse line. Although innervation by layer VI fibers had not yet begun at P0,
aggrecan-IR was substantially reduced in the perinatal mouse, and aggrecan was
degraded in the same manner as the golli-tau-gfp with signal loss at the medial border
of dLGN and increased IR towards the lateral edge (Figure 12A). By P1, aggrecan-IR
had been substantially reduced towards the lateral edges of dLGN; coincidentally, layer
VI fibers began to enter the dLGN at this early age in the absence of retinal inputs. By
P2, cat315 signal could no longer be observed throughout most of dLGN except the far
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lateral edges near the optic tract, and CG fibers had begun extending across the dLGN.
By P3 aggrecan-IR only covered ~5% of the dLGN and layer VI CG axons were
observed to innervate significantly more area of dLGN compared with golli-tau-gfp mice
(Figure 12 B). P1-P3 images of math5-/- mutants illustrate the principle that GFPlabeled layer VI fibers only enter the dLGN and extend to portions where aggrecan-IR is
minimal (Figure 13). At ages P4 – P7, aggrecan proteoglycan expression remained
nearly undetectable within dLGN, and the CG fibers continued to move laterally across
the dLGN spanning 80% of dLGN by P7 (Figure 12).
We compared the spatial extent of dLGN coverage by aggrecan-IR and GFP-IR
in both the golli-tau-gfp and the math5-/- animals. Statistical analyses of both models
validated the observations that aggrecan protein levels diminished during postnatal
development and CG fibers only entered the dLGN where aggrecan protein coverage
was sufficiently low. P0 mice had the highest levels cat315 labeling in both golli-tau-gfp
and math5-/-mice, but the golli-tau-gfp mice showed more uniform high intensity signal
across the entire dLGN, while math5-/- mice already had significantly diminished
aggrecan levels in the ventromedial dLGN. Aggrecan-IR was apparent in only 40% of
the dLGN in math5-/- mice compared to the 80% in golli-tau-gfp tissue (Figure 14). At
P1, cat315 signal in math5-/- mice only appeared in less than 25% of dLGN and in some
mice, CG axons could innervate dLGN. At P1, CG axons in golli-tau-gfp mice remained
arrested in the eml, and aggrecan-IR covered 70% of dLGN. At P2, aggrecan in the
golli-tau-gfp animals decreased sharply with IR presented only over 40% of dLGN;
however, the math5-/- mouse line exhibited extremely low aggrecan-IR with only 5-10%
coverage of dLGN. The low levels of aggrecan throughout dLGN made for a permissive
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environment into which CG axons could begin innervation in all math5-/- mice. By P3,
aggrecan levels had decreased dramatically and layer VI cortical fibers in the golli-taugfp mouse began to project slightly out of eml into dLGN, but the math5-/- model had a
significant increase in the area of dLGN covered by layer VI fibers which correlated with
the early degradation of aggrecan. P3 also represented the age at which both aggrecan
and GFP-IR showed significantly different levels between golli-tau-gfp mice and math5-/mice. At subsequent ages, aggrecan levels continued to recede in the golli-tau-gfp
mice, while the CG fibers continued to innervate the dLGN until P14. From P4 to P7,
the math5-/- line had a much quicker cortical fiber progression and significantly more
dLGN area innervated. 80% of the dLGN was covered by GFP-containing fibers at P7 in
the math5-/- animals (Figure 14). Taken together, these data suggested that high levels
of aggrecan in dLGN repel layer VI CG projections into dLGN.

Conclusions
Aggrecan was present at perinatal ages in high concentrations in dLGN and
likely serves as an inhibitor of layer VI GFP-expressing axons that approach the dLGN.
Although transcription of aggrecan increased during postnatal development, the signal
of aggrecan-IR decreased within the dLGN suggesting that it must be regulated either at
a translational level or by other molecules in CNS. Aggrecan-IR was inversely
correlated with the invasion of dLGN by CG fibers in both golli-tau-gfp and the math5-/mouse models. These data strongly support a role for aggrecan in the inhibition of layer
VI axon invasion of dLGN, and they implicate retinal input in the regulation of aggrecan.

49

Figure 7: Aggrecan protein is enriched in perinatal dLGN. Immunostaining in dLGN of
five different CSPGs: brevican, neurocan, versican, phosphacan, and aggrecan. Plot
profiles accompanying each image indicate fluorescent intensities of IR in individual
pixels as measured with a line scan along the ventrolateral to dorsomedial axis of LGN
(see dashed line in brevican image). Grey lines represent IR in separate animals, and
the black line depicts the mean of all grey lines (n=4). Plots were divided to show
fluorescent intensities as the line scan transitions from vLGN to dLGN. Scale bar is 250
µm. dLGN are encircled with white dots
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Figure 8: Schematic of domains in aggrecan protein. Aggrecan is a bulky ECM protein
that is composed of multiple functional domains. The N-terminal globular domain (G1)
associates with hyaluronan and link proteins to form large aggregates of extracellular
matrix, hence the name aggrecan. G1 is followed by the IGD, and the second globular
domain (G2) has unknown function but is conserved across species for the aggrecan
protein. Following G2 is a short length of protein containing keratan sulfate
glycosaminoglycans chains (KS-GAGs), which precedes a long section of unfolded
protein attached to CS-GAGs (Aspberg, 2013). The CS domain is reported to be the
repellant domain of functional aggrecan, as specific CS-GAG patterns have been
reported to alter neurite extension in vitro at levels comparable to intact aggrecan
(Gilbert et al., 2005). Finally, the C-terminal globular domain (G3) associates with other
ECM molecules to function in the organization of ECM (Aspberg, 2013).
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Figure 9: Developmental regulation of aggrecan during the first two weeks of postnatal
development. (A) qPCR results illustrating increased aggrecan mRNA expression in
dLGN during visual system development. Error bars in qPCR data are +/- standard
deviation (SD) (B) . Immunostaining using the antibody cat315, specific for aggrecan,
depicting the dramatic decline of aggrecan-IR from P0 to P10. Inset shows lack of
aggrecan-IR in dLGN of acancmd mouse. Scale bar in B is 250 µm.
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Figure 10: Decreased aggrecan-IR coincides with layer VI CG axon innervation in gollitau-gfp mice. (A) Immunostaining using antibodies to label aggrecan (top) and layer VI
GFP-containing axons (middle) in golli-tau-gfp tissue from P0 – P7. Bottom row
contains merged images of aggrecan (red) and CG fibers (green) to illustrate the lack of
colocalized signal and coincident timing of layer VI dLGN innervation with aggrecan
loss. dLGN are encircled by white dots. Scale bar is 200 µm. (B) The percentage of
dLGN occupied by aggrecan-IR was measured in golli-tau-gfp transgenic mice for the
first 8 days of postnatal development. The percentage of cortical innervation in these
mice was also quantified. Error bars are shown +/- standard error of the mean (SEM).
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Figure 11: Math5-/- mutants lack RGC innervation to LGN. Labeling of LGN in WT and
math5-/- mouse lines using DiI. WT mouse (Left) labeling depicting robust fluorescent
signal in the optic tract and dLGN, while the math5-/- mice (Right) lack labeling due to
genetic ablation of RGCs. Scale bar is 250 µm. dLGN are encircled with white dots.
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Figure 12: Aggrecan loss in dLGN is accelerated in math5-/- mice. (A) Immunostaining
using antibodies to aggrecan (top) and layer VI GFP-containing axons (middle) in
math5-/-tissue from P0 – P7. Bottom row contains merged pictures with aggrecan (red)
and CG fibers (green) to illustrate the coincident timing of layer VI dLGN innervation
with aggrecan degradation. dLGN are encircled by white dots. Scale bar is 200 µm.
(B) The percentage of dLGN occupied by aggrecan-IR was measured in math5-/transgenic mice for the first 8 days of postnatal development. The percentage of
cortical innervation in these mice was also quantified. Error bars are shown +/- SEM
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Figure 13: Layer VI fibers enter dLGN where aggrecan-IR is lowest. P1-P3 enlarged
images from the math5-/-. Arrowheads depict the remaining aggrecan-IR in the lateral
aspect of dLGN. Arrows highlight GFP-labeled axons prematurely invading dLGN. Note
the absence of aggrecan in areas of cortical axon invasion. dLGN are encircled by
white dots. Scale bar = 100 µm.
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Figure 14: Retinal Inputs influence the loss of aggrecan in dLGN. The % dLGN
occupied by tau-GFP expressing axons (top graph) or by aggrecan-IR (bottom) was
compared in math5-/- mutants and golli-tau-gfp controls. Error Bars are +/- SEM. *
denotes a difference with statistical significance of p<.01 by Tukey-Kramer test.
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Chapter IV
Aggrecan Prevents Cortical Axon Growth into dLGN

Introduction
Although the inhibitory domain of aggrecan can repel RGC axons, regenerating
fibers in spinal cord, and numerous other classes of axons, it does not repel all cell
types (Snow et al., 1992; Silver et al., 2004). Serotonergic neurons in the spinal cord
represent a class of cells that show enhanced outgrowth onto aggrecan rich substrate
(Hawthorne et al., 2011). Having examined the expression of aggrecan and its potential
role as a regulator of layer VI cortical afferents, I sought to characterize the direct effect
of aggrecan protein on the growth and outgrowth of neurons located in layer VI of visual
cortex. To better gauge if aggrecan was sufficient to repel CG fibers from layer VI, I
used in vitro analysis to determine the effect of aggrecan on disassociated layer VI
GFP-expressing neurons and their neurites. Once the signaling capabilities of
aggrecan on layer VI axons were determined, I employed in vivo analyses to better
understand the necessity of aggrecan in regulating the timing of CG innervation.

Aggrecan was sufficient to repel layer VI axons from dLGN
I utilized a modified stripe assay to determine whether aggrecan could repel
dissociated cortical neurons. First I established that I could reproducibly grow healthy
layer VI neurons in culture (data not shown). As a separate control, I spotted BSA
conjugated to alexa-fluor 594, which I used to visualize the spots on the culture plates,
at the same concentration that I mixed with aggrecan, to ensure that there were no
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effects, either attractive or repulsive, on the growth of layer VI neurons and their
processes (data not shown).
At low concentrations of aggrecan (1µg/ml), neurites from layer VI neurons could
project throughout the aggrecan-containing substrates and across the borders of the
aggrecan covered area (Figure 15A). At 5µg/ml and 10µg/ml, viable GFP-expressing
neurons were not observed within the aggrecan containing substrates. Moreover,
neurites from layer VI neurons would not extend into the aggrecan covered regions;
therefore, aggrecan inhibited layer VI cortical neurite outgrowth (Figure 15 B,C). I also
pretreated aggrecan with chABC, an enzyme derived from bacteria that effectively
degrades the inhibitory CS-GAG side chains. Layer VI neurons could extend into
regions of the chABC-treated aggrecan (Figure 15 D). The chABC treatment illustrated
two important principles: First, the inhibitory domain of aggrecan was embedded in the
GAG side chain domain, and it also showed that inhibition was not caused by a physical
boundary due to a protein barrier. Quantification of the neurites’ ability to cross into the
aggrecan substrate revealed that high concentrations of aggrecan repel significantly
more neurites than low concentrations of aggrecan and aggrecan that had been
degraded by chABC (Figure 15 E).

Degradation of the CS domain of aggrecan alters CG innervation profile
After I established that aggrecan was sufficient to inhibit layer VI cortical neurite
outgrowth in vitro, I was interested in testing whether premature digestion of the CSGAGs attached to aggrecan would result in accelerated layer VI CG axon entry in vivo.
I performed bilateral intrathalamic injections of chABC in golli-tau-gfp mice to determine
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the necessity of aggrecan in CG timing and compared these data to age matched
uninjected littermates. As an additional control to account for the CNS injury received
during injection, I also injected littermates with PNase, an enzyme of comparable size
and bacterial origin with no known effects within CNS tissue. I then analyzed CG
innervation in each of the treatment conditions.
My experimental dosing regimen was based on previous chABC treatments
used in spinal cord injury (SCI) therapies that were known to allow regenerating axons
to overcome CSPG inhibition (Steinmetz et al, 2005; Massey et al., 2006; Alilain et al.,
2011). These studies reported that chABC must be injected within 1mm of the area of
interest in order for distribution to a specific site. After making a tiny incision in the
scalp to locate coordinates on the brain to place my injection, I placed the micropipette
through the cortex in the medial thalamus approximately 0.5mm from the dLGN to
preserve cytoarchitecture and prevent gliosis within dLGN which might affect my results
(Figure 16 A). Using a picospritzer, I delivered controlled volumes of drug into the CNS
of P0-P1 golli-tau-gfp mice.
Upon examination of CG innervation, two days following drug delivery, I
observed a significant increase in the area of dLGN covered by axons in the chABCinjected animals compared to uninjected age matched control littermates (Figure 16B,
C). PNase injected golli-tau-gfp mice exhibited a CG innervation phenotype that was
insignificantly different from uninjected age matched littermates but showed significantly
lower area of coverage when compared to the chABC injections (Figure 16B,C).

Aggrecan prevents layer VI axons from entering the dLGN
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ChABC non-specifically destroys the CS-GAG side chains of all CSPGs.
Although I established that aggrecan was the most abundant lectican CSPG localized in
dLGN during perinatal development, IHC results revealed that other CSPGs were also
present in dLGN. In order to interpret the necessity of aggrecan and exclude
interactions from CS-GAG chains on other CSPGs, I needed to specifically target
aggrecan and ensure that CS-GAGs from other proteoglycans were not directly affected
by chABC enzymatic digestion. For this I used a mouse model with a spontaneous
mutation in the acan gene (acancmd). This mutation results in the translation of a nonfuntional aggrecan molecule that lacks the CS domain. Due to the lack of functional
aggrecan protein globally, these homozygous mutant mice exhibit many severe
phenotypes including perinatal death due to an inability to breathe.
By cross-breeding the acancmd mouse line to the golli-tau-gfp mouse line, I was
able to observe the effect of ridding the CNS of aggrecan, exclusively, on the timing of
CG projections without destroying the cytoarchitecture or introducing pharmacological
side-effects such as degradation of CS-GAGs on other proteoglycan molecules.
Aggrecan was expressed throughout the thalamus during embryonic
development of mice, and aggrecan was degraded in a pattern from ventral to dorsal
thalamus during prenatal and perinatal development (Data not shown). Given these
observations, I believed that CG innervation would be accelerated in the acancmd mouse
because of a lack of inhibitory cues to stop the growth cones of invading axons. My
results confirmed the necessity of aggrecan in regulation of the timing of layer VI cortical
projections in dLGN. In the acancmd mice that were homozygous for WT aggrecan and
acancmd mutants, I compared the progression of layer VI fibers into thalamus at P0. In
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WT sections of rostral LGN, GFP expressing axons began to approach the dLGN, but
there were very few projections labeled. Since the LGN is a long structure, I also
analyzed sections located in both the middle of the LGN and caudal LGN to see if layer
VI axons were more abundant within a particular section, or if the GFP-expressing
projections had progressed further into dorsal thalamus or along the eml. In the areas
of middle LGN, axons were located near the most ventral areas of the vLGN of WT
mice, nowhere near dLGN at this point (Figure 17 A). Finally near the caudal end of
LGN, where vLGN was very large, I observed that layer VI afferents were absent from
areas adjacent to the vLGN. These results starkly contrasted my findings in the acancmd
mouse, where layer VI fibers were not only quite abundant near rostral, middle, and
caudal dLGN, but I could also see that the axons had progressed much further along
the eml. In all three sections, axons were present travelling as far as the IGL, with
many projections lining up in eml along medial dLGN in more rostral sections. Upon
closer inspection, pioneer axons (denoted by arrows) could be seen in the tract adjacent
to and even coursing through parts of dLGN in rostral, middle and caudal sections
(Figure 17B).
The outgrowth profile of layer VI axons into thalamus demonstrated a vast
difference between animals that had normal aggrecan profile and those that could not
produce functional aggrecan. In several cases, I observed multiple fine CG fibers
coursing into dLGN (Figure 18).

Conclusions
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In vitro experiments illustrated that aggrecan was repulsive to layer VI neurites in
high concentrations, and the functional domain for inhibiting neurite outgrowth resided
within the CS-GAG domain of aggrecan. An interesting observation from the in vitro
analyses was a potential concentration dependent effect of aggrecan inhibition on layer
VI neurites, suggesting a differential effect on axons within the population of layer VI
cells. The destruction of aggrecan at perinatal ages with chABC in vivo led to
accelerated CG innervation, complementing previous data from the math5-/- time series
experiments that suggested early loss of aggrecan allowed accelerated CG entry into
dLGN. Finally the acancmd mutant mouse line provided evidence that layer VI GFPexpressing fibers could innervate the dLGN as early as P0 in the absence of aggrecan.
Taken together these data showed that aggrecan was sufficient to repel layer VI axons
from the dLGN, and aggrecan was necessary in the proper spatiotemporal development
of CG axons in thalamus.
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Figure 15: Layer VI neurite outgrowth is inhibited by high levels of aggrecan in vitro.
(A-D) Aggrecan covered substrate containing low concentration (1µg/ml), high
concentrations (5 µg/ml and 10 µg/ml), and an enzymatically deactivated (10 µg/ml +
chABC) concentration of aggrecan are labeled in red. Tau-GFP expressing cortical
neurons labeled with GFP antibody in green. Scale bar is 50µm. (E) Quantification of
the percentage of neurites capable of crossing into aggrecan containing substratum in
conditions shown in A-D. Error bars are +/- SEM. ** marks a difference with statistical
significance p<.01 by ANOVA with Tukey-Kramer post-hoc test.
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Figure 16: Premature digestion of aggrecan accelerates CG innervation in vivo. (A)
Schematic depiction of the site of bilateral intrathalamic injections. (Image of cresyl
violet stained coronal section of brain modified from Allen Institute for Brain Science).
(B) Top row shows GFP-labeled axon invasion at P3 following injection of PNase at low
(left) magnification and area highlighted by arrows at high (right) magnification. Bottom
row depicts GFP labeled axon invasion at P3 following injection of chABC at low (left)
magnification and area highlighted by arrows at high (right) magnification. dLGN are
encircled with white dots. Scale bar for low magnification images is 150 µm. Scale bar
for high magnification images is 20µm. (C) Quantification of the percent dLGN
innervated by GFP-containing cortical axons at P3 following neonatal injection of PNase
or chABC. Data are normalized to data obtained from uninjected golli-tau-gfp
littermates and error bars are +/- SEM: n>7. * chABC treatment is statistically different
from PNase treatment by p<.02. **chABC treatment is statistically different from
uninjected controls by p<.0005.
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Figure 17: Pioneer axons from layer VI cortical neurons advance further into thalamus in
the absence of functional aggrecan. Left panel shows regular (left) and inverse (right)
images layer VI axon progression in sections of rostral, middle, and caudal LGN in WT
golli-tau-gfp mouse. Arrows show how far pioneer axons have reached in each section
by P0. Right panel depicts similar sections in age matched acancmd mutants which lack
aggrecan protein. Arrows show that pioneer layer VI fibers advanced much further, and
they are located within dLGN in some cases. Scale bar is 250 µm.
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Figure 18: Multiple layer VI CG axons can be found in dLGN of acancmd mutants at P0.
Low (left) magnification image shows at least two axons (highlighted by arrows) within
dLGN in acancmd mutants. High-magnification inverse image (right) highlights the fine
processes of multiple fibers (arrows) and large bulbous growth cones. Low
magnification scale bar is 100µm. Scale bar in high-magnification image is 50µm.
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Chapter V
Retinal Inputs Regulate Aggrecanases

Introduction
Earlier in this manuscript, I introduced the phenomenon that genetic removal of
retinal inputs to dLGN caused aggrecan levels to decrease and accelerated the timing
of CG innervation (Figure 12). Due to the reduction of aggrecan in the math5-/animals, I hypothesized that retinal input to dLGN relay neurons influences the
distribution of aggrecan. Since I previously reported that aggrecan mRNA levels
consistently increase from birth until eye opening and do not correlate with aggrecan
protein levels by IR, I attempted to uncover the regulatory elements involved in
aggrecan degradation.
Further exploration of literature revealed the ADAMTS family of extracellular
proteases that possess aggrecanase activity. Prompted by this new information, I
sought to examine the expression profiles of ADAMTS members in both golli-tau-gfp
and math5-/- mice. Once I determined the presence of adamts gene transcripts in vivo, I
was interested in exploring the mechanism by which adamts mRNA is regulated. I
employed FISH using adamts probes and transcriptional profiles, comparing mRNA
expression in golli-tau-gfp and math5-/- mice, to characterize the role of retinal input on
the regulation of adamts family members. Furthermore, I performed plot profile
comparisons of the fluorescent intensity and displacement of the layer VI afferents
projecting into dLGN in golli-tau-gfp, math5-/-, PNase-, chABC-, and ADAMTS4-injected
mice to illustrate how premature aggrecan degradation led to advanced CG innervation.

80

Finally, I designed a model describing the mechanisms elucidated in this dissertation
that regulate the timing of CG innervation.

Role of ADAMTS in timing of CG innervation
Despite the dramatic changes in aggrecan protein levels during postnatal dLGN
development, preliminary qPCR analyses detected increases in mRNA transcript
expression of the gene acan, which encodes aggrecan. Although there is not a 1:1 ratio
that determines every transcribed gene product must be translated into protein, I was
surprised by this data and suspected that there must be an extracellular enzyme
responsible for the decline of aggrecan-IR signal in dLGN.
Although my initial transcriptional profiling experiments did not identify aggrecan
or other potential regulators of CG timing, they demonstrated an enrichment of
extracellular protease mRNAs in postnatal dLGN. Specifically, I observed an increase
in several members of the adamts gene family in a microarray comparing expression of
P3 dLGN and vLGN. At this age, when layer VI axons were just beginning to enter
dLGN in the golli-tau-gfp mouse, I found that adamts4, adamts8, adamts15, and
adamts19 were all significantly enriched in dLGN (Figure 20 A).
ADAMTS proteins are a class of extracellular enzymes that function in cleavage
and degradation of a plethora of extracellular molecules. Many studies have focused on
characterizing the enzymatic cleavage activities of the ADAMTS proteases, specifically
on aggrecan, to determine which family members constitute the most effective
“aggrecanase” (Totorella and Malfait, 2008; Stanton et al., 2011). The results of those
studies concluded that nearly half of the known ADAMTS family members have an
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affinity for at least one domain located on aggrecan protein including ADAMTS1,4,5,8,9,12,15,16,18, and 19 (Figure 19).
This experiment provided evidence for a potential mechanism for aggrecan
degradation at the early ages, but I also needed to ensure that adamts family members
continued high levels of expression in order to maintain low aggrecan levels. Thus, I
employed a longitudinal microarray comparing levels of mRNA expression in dLGN of
P3 and P8 animals, and I observed that even more “aggrecanases” were upregulated
including adamts1, adamts8, adamts9, adamts10, adamts12, adamts15, adamts19
(Figure 20 B). I confirmed significant developmental increases in mRNA expression for
adamts4, adamts8, adamts9, adamts15, and adamts19 through qPCR comparisons in
dLGN at P2 and P14 (Figure 22 B).

ADAMTS family members produced by relay neurons
The transcriptonal profiles provided me with an excellent starting point for
selecting candidate molecules. Due to the unavailability of specific antibodies to label
ADAMTS members, I synthesized riboprobes specific to adamts family members for in
situ hybridization of developmental tissue. FISH enabled a better understanding of what
cells are making the enzymes and any distinct patterns of generation or localization
within the dLGN. I was successful in generating probes for both adamts4 and
adamts15. D-FISH colocalization experiments, using the adamts probes and a probe
for gene product of syt1 (synaptotagmin 1,) to label excitatory neurons in dLGN, allowed
me to identify that both adamts4 and adamts15 were produced by relay neurons in the
dLGN (Figure 21).
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Although I could not be sure if one or all of the ADAMTS enzymes mediated
aggrecan degradation in dLGN, my results implicated adamts4 and adamts15 as viable
candidates. I observed that the expression of adamts15 in P3 WT mice occurred in a
ventromedial to dorsolateral gradient in dLGN which closely resembled the pattern of
early aggrecan degradation (Figure 22). By P14 adamts15 expression localized in the
dLGN was expressed robustly in relay neurons throughout the dLGN (Figure 22).

Aggrecanases regulated by retinal input
Based upon the upregulation of aggrecanase mRNAs coincident with aggrecan
degradation in golli-tau-gfp dLGN, I suspected that the expression or activity of these
metalloproteinases may be regulated by retinal input. ISH probes for adamts4 and
adamts15 were applied to math5-/- tissue to determine if any differences existed,
pertaining to expression early in development, when aggrecan levels were already
diminished in these mutants. I identified high levels of expression of adamts4 in these
mutants at P3 and P6, and I also observed adamts15 expression in dLGN at P0, as well
as, P3 and P6 (Figure 23 A).
I also performed a microarray comparing P3 dLGN mRNA expression in golli-taugfp and math5-/- mutants to determine if other guidance molecules were altered in the
absence of retinal input. Although I did not find the expression of inhibitory guidance
molecules, including acan expression, to be altered significantly in the math5-/- mutants,
I discovered a modest increase in many of the adamts family members that contain
aggrecanase activity, including adamts4, adamts8, adamts9, adamts15, and adamts16
(Figure 23 B). Adamts12 mRNA levels were significantly upregulated, and there was
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also a significant 27% increase amongst the entire family of adamts aggrecanases.
Since the ADAMTS enzymes have redundant functions, I believe that these increases
provide ample explanation for early aggrecan degradation in the math5-/- mice.

ADAMTS4 degradation of aggrecan allowed accelerated CG invasion of dLGN
Next I tested whether aggrecanases contributed to the timing of CG innervation
by injecting constitutively active, rhADAMTS4 into the thalamus of neonatal golli-tau-gfp
pups. ADAMTS4, dubbed aggrecanase-1, was chosen over the other ADAMTS
enzymes for multiple reasons. In contrast to most other ADAMTS enzymes, active
ADAMTS4 was commercially available. Second, ADAMTS4 was capable of cleaving
the aggrecan molecule at multiple sites within the IGD and CS domains of aggrecan,
whereas, many of the other metalloproteinases were only capable of cleaving at one
particular site on the aggrecan molecule(Tortorella and Malfait, 2008). Finally, in
addition to cleaving the same sites as other ADAMTS enzymes, ADAMTS4 had an
affinity for aggrecan that was several orders of magnitude higher than most others
(Tortorella and Malfait, 2008). This combination provided confidence that exogenous
delivery ADAMTS4 was the most suitable ADAMTS family member to specifically target
and degrade aggrecan in vivo.
I utilized the same intrathalamic injection paradigm for ADAMTS4 that I used in
the chABC experiments. When I assessed the amount of CG innervation at P3, I
observed that layer VI fibers in the PNase injected animals resembled the phenotype in
uninjected animals, but layer VI axons in the ADAMTS treated cohort traveled further
into dLGN (Figure 24A). Not only did GFP labeled fibers extend further into dLGN, but
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also the amount of area occupied by CG projections as detected by threshold analysis
was significantly higher for the ADAMTS4-injected animals compared to both uninjected
littermates and PNase-injected animals (Figure 24B). Although both chABC and
ADAMTS4 injections significantly altered CG innervation compared to controls, they did
not show statistical differences between each other.

Pharmacological models of aggrecan degradation showed similar CG innervation profile
to math5-/- mutant mouse model
Another compelling piece of evidence for retinal regulation of aggrecanase
enzymes came from performing plot profiles using line scans to quantify axon
progression from the medial to lateral boundaries of dLGN in golli-tau-gfp, math5-/-,
ADAMTS4-treated, chABC-treated and PNase-treated brain sections stained with GFP
at P3. The plot profiles recorded both fluorescence intensity, which related to the
number of axons present in any pixel, and distance traveled from eml into the dLGN
providing a detailed account of the innervation profile. I performed plot profiles and
averaged the data for n=8 for the math5-/- and golli-tau-gfp brains, and n=3 for each of
the treated brains.
The math5-/- animals showed the greatest lateral extent of CG axon entry into
dLGN, and they maintained the highest fluorescent intensity over the first 50µm into
dLGN. Axons from both the ADAMTS4 and chABC-treated animals began entering the
dLGN with intensities comparable to the math5-/- model; however, the plot profile for
chABC began to diverge from the other two scans just 5.4 µm into dLGN. The
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ADAMTS4 plot profile mimics the profile of math5-/- mice until nearly 15µm inside dLGN
(Figure 25).
GFP-expressing axons in both the golli-tau-gfp and PNase-treated animals
began entering the dLGN with fluorescent intensities that were ~2/3 of the signal
observed in axons from math5-/- animals. This data suggested that fewer axons were
entering dLGN from eml in golli-tau-gfp and PNase-treated mice. The plot profiles for
golli-tau-gfp and PNase treated mice were similar and appeared “distinct” from the data
obtained from either ADAMTS4-injected animals or math5-/- mutants (Figure 25). This
descriptive analysis combined with the statistically significant increase in dLGN
coverage by layer VI axons in ADAMTS4-injected animals suggested that ADAMTS4
could potentially be the adamts family member that is directly regulated by retinal input
in vivo.

Conclusions
Microarray analyses provided evidence for upregulation of ADAMTS family
members in dLGN, which was concomitant with the decreased signal in the aggrecan
IHC experiments. These data confirmed a potential molecular mechanism for the
regulation of aggrecan during the development of the visual system. The D-FISH results
suggested that relay neurons, not interneurons or glial cells, were the primary synthetic
site of adamts mRNA transcripts. Along with the IR labeling and transcriptome profiling
in the math5-/- mouse model, the data implicate retinal inputs as serving an instructional
role on aggrecanase expression. Finally, I determined that ADAMTS4 was sufficient to
degrade aggrecan in vivo and accelerate the timing of CG innervation. Comparisons of
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CG innervation, at P3 in my experimental models, illustrated that early aggrecan
degradation allows for more axons to project further into dLGN. These results
supported my hypothesis concerning an endogenous regulatory mechanism for CG
timing in CNS; specifically, relay neuron derived ADAMTS contributed to the
developmental degradation of aggrecan.

Summary
To summarize, I created a simplified model to illustrate the mechanisms that
regulate the timing of CG innervation during visual system development in the mouse
dLGN. At perinatal ages, immature retinal axons had already begun to innervate the
dLGN and had formed many weak synapses onto relay neurons throughout the dLGN.
During that period of time, aggrecan was present in the ECM across the entire dLGN.
Retinal signaling of the relay neurons produced a response that inhibited expression of
adamts family members. At around P4, retinal synapses began differentiation, where
strong synaptic partners were retained, and weak synapses, or improperly formed
synapses, were retracted in order to form other contacts. At that time, the inhibition of
ADAMTS expression was released and aggrecan degradation had begun, allowing CG
fibers entry into dLGN. As development progressed, RG synapses began to mature,
ADAMTS expression was greatly increased, and aggrecan continued to be destroyed.
This process allowed for CG projections to extend across much of dLGN and form weak
synapses onto relay neurons. Around the time of eye opening (P14), CG fibers finally
began exhibiting mature synaptic contacts as RG synapses took on their adult profile,
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presumably to allow CG feedback afferents to form specific connections onto the proper
relay neuron (Figure 26).
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Figure 19: ADAMTS4 is capable of cleaving aggrecan at multiple sites. Matrix
metalloproteinases (MMPs) cleave aggrecan at one site within the IGD. At least 5 sites
have been identified as targets for ADAMTS4 cleavage on the aggrecan molecule, one
site within the IGD and 4 others within the CS domain which create different size
cleavage fragments (Porter et al., 2005). ADAMTS4 recognizes the IGD cleavage
domain with at least 100X greater efficiency than most other ADAMTS enzymes and
can overcome aggrecan inhibition more effectively than MMPs (Cua et al., 2013). The
major cause of aggrecan depletion is due to cleavage at the IGD site, however, the
ADAMTS4 CS-domain cleavage has been hypothesized to result in bioactive fragments
that could be conducive to neurite outgrowth, based on previous reports of bioactive
molecules resulting from partially digested ADAMTS fragments from other CSPGs
including versican and brevican (Cua et al., 2013; Sandy et al., 1991; McCulloch et al.,
2009; Viapiano et al., 2008)
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Figure 20: Aggrecanases are upregulated in postnatal dLGN. (A) Microarray
comparison of gene expression in P3 dLGN compared to vLGN revealed that several
members of the adamts family of proteases were upregulated in dLGN. Blue bars
indicate adamts known to possess aggrecanse activity. Error bars are +/- SEM: n=3. *
means difference is significant by p<.05 by T-Test, ** means difference is significant by
p<.01. (B) Microarray comparison of gene expression in P3 dLGN compared to P8
dLGN revealed that several members of the adamts family of proteases increase over
time during visual development. Blue bars indicate adamts known to possess
aggrecanse activity. Error bars are +/- SEM: n=3. * means difference is significant by
p<.05 by T-Test, ** means difference is significant by p<.01.
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Figure 21: Relay neurons produce adamts mRNA transcripts. (Top panel) In situ
hybridization in P14 coronal sections of dLGN revealing the presence of adamts15 (left)
and syt1 (middle left) illustrating colocalization (middle right). (Bottom panel) In situ
hybridization in P14 coronal sections of dLGN showing adamts4 (left) and syt1 (middle
left) and colocalization (middle right). High-magnification images of each overlay (Far
Right) clearly show colocalization of both adamts15 and adamts4 in relay neurons.
Scale bar for low-magnification images is 200 µm. Scale bar for close up overlay
images is 75µm.
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Figure 22: Increased longitudinal gene expression of adamts family members confirmed
in golli-tau-gfp mouse. (A) ISH for adamts15 showing localization in dLGN at P3 and
P14. Scale bar is 200µm. (B) qPCR of relative expression from P2 to P14 shows that
multiple aggrecanse genes are upregulated over time in dLGN.
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Figure 23: Removal of retinal inputs increases adamts expression in postnatal dLGN.
(A) ISH for adamts4 (top panel) showing robust expression in dLGN at P3 and P6.
Adamts15 (bottom panel) was also detected in perinatal dLGN. Scale bar is 200µm. (B)
Microarray comparison of P3 golli-tau-gfp and math5-/- dLGN unveiled modest changes
in multiple adamts family members that possess aggrecanase activity (blue bars).
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Figure 24: ADAMTS4 digestion of aggrecan accelerates CG innervation. (A) PNase
(Top panels) injected tissue immunostained with GFP showing little CG axon entry into
dLGN. Left Panel represents low-magnification image, and right panel is highmagnification image focused on boxed area. ADAMTS4 injected tissue (Bottom panels)
showing layer VI fiber extending farther into dLGN. Left Panel represents lowmagnification image, and right panel is high-magnification image focused on boxed
area. Scale bar for low-magnification images is 150µm. Scale bar for highmagnification images is 20µm. (B) Quantification of the percent of dLGN innervated by
layer VI GFP-expressing cortical axons in PNase and ADAMTS4 treated tissues.
*ADAMTS treatment is statistically significantly different from PNase injections by
p<.0001 by ANOVA with Tukey-Kramer post-hoc test.
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Figure 25: Neonatal injection of ADAMTS4 produces CG innervation profile similar to
math5-/- mice at P3. Averaged plot profiles from medial dLGN to lateral dLGN in P3
math5-/- (red), golli-tau-gfp (green), PNase-injected (yellow), chABC-injected (blue), and
ADAMTS4-injected (black) mice depicting fluorescent intensity of invading GFP fibers,
as well as, displacement from eml into dLGN. Note the clustering of math5-/-, chABCinjected and ADAMTS4-injected fluorescence intensities at the medial border and
displacement into dLGN.
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Figure 26: Retinal inputs instruct the timing of CG innervation through the modulation of
aggrecan. Left: As immature retinal inputs (red lines) form weak connections with relay
neurons (large purple circle) at neonatal ages, aggrecanases (yellow) are inhibited from
being expressed and aggrecan (blue bars) is present throughout dLGN. CG axons
(green lines) remain outside of dLGN. Middle: Around age P4, retinal inputs to the
mouse dLGN begin differentiation to form mature synaptic contacts, the signal for
inhibition of ADAMTS is released and aggrecan can be degraded. Coincidentally, CG
inputs begin entering dLGN in areas where aggrecan has been degraded. Right:
Retinal synapses continue to mature and become larger at P7, aggrecanase production
is greatly increased leading to rapid aggrecan turnover, and CG axons begin to extend
much further into dLGN and form synaptic contacts.
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Chapter VI
Discussion

Understanding the mechanisms that drive both the timing and distribution of
retinal and non-retinal inputs onto relay neurons in dLGN is important as I sought to
elucidate mechanisms that coordinate the formation of multiple inputs in one target
region. During this project, I have identified a novel role for aggrecan, an inhibitory
CSPG enriched in neonatal mouse dLGN, in preventing the premature invasion of
cortical axons into dLGN, and I believe that discovering mechanisms that regulate the
timing of innervation in the CNS will likely contribute to the development of targeted
therapies for pathological conditions that effect axon guidance and synaptic targeting.
Relay neurons in the dLGN project thalamocortical axons to layer IV of visual
cortex. Different sets of cortical neurons in layer VI of visual cortex send descending
corticothalamic (CT) axons to form reciprocal, feedback connections onto relay neurons
in dLGN (Sherman and Guillery, 2002). Waiting periods for growing axons have been
reported in the chick hindlimb and the spinal cord, and the purpose of the waiting period
is hypothesized to allow for maturation of axonal targets (Sharma et al., 1994; Wang
and Scott, 2000; Deck et al., 2013). My results indicate that RGCs are beginning to
form functional synapses and differentiation just prior to the degradation of the aggrecan
stop signal and layer VI fiber entry into dLGN. These results suggest that the function
of the aggrecan mediated delay of CG innervation is congruent with previous reports of
waiting periods in the CNS.
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Distinct cellular populations react differently to aggrecan
Aggrecan is one of the most well characterized CSPGs in the CNS. Reports
have illustrated that the growth of many types of axons can be inhibited by aggrecan
(Snow and Letourneau, 1992).

In response to SCI, aggrecan secretion by reactive

astrocytes limits the amount of axon regeneration at the glial scar, and aggrecan is the
focus for therapies to facilitate functional regeneration in the injured spinal cord
(McKeon et al., 1991; Silver and Miller, 2004; Busch et al., 2009). Recent evidence has
been provided showing that serotonergic neurons in the spinal cord exhibit an unusual
viability and axon sprouting in the aggrecan rich glial scar; therefore, aggrecan does not
have the same effect on all cell types (Hawthorne et al., 2011). My results showed that
layer VI cortical neurites were repelled by aggrecan in vitro. Combined with in vivo
analyses and manipulations, I concluded that aggrecan was not only sufficient to repel
layer VI axon outgrowth but also was necessary to delay CG fiber invasion in dLGN.
These results also presented a fascinating paradox. Previous studies have
shown that aggrecan inhibits retinal axon outgrowth in vitro; however, aggrecan in
dLGN prevented CG innervation from P0-P3 while permitting RG innervation and
synapse development (Snow and Letourneau, 1992). My observations could be
attributed to differing cells abilities to overcome aggrecan inhibition through interactions
with particular growth-promoting substances, such as laminin or neurotrophin-3 (Snow
et al., 1990; Fawcett, 2006). There is also evidence that embryonic neurons can
overcome the inhibition presented by high concentrations of aggrecan by altering the
expression levels of integrin receptors in their cell surface (Condic et al., 1999; Tan et
al., 2011). Lack of aggrecan inhibition may also be explained, in part, by complexity of
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in vivo systems in which aggrecan can mediate inhibition through at least 4 different
receptors including the leukocyte antigen-related protein tyrosine phosphatase receptor
(LAR), protein tyrosine phosphatase sigma (PTPσ), nogo receptor 1 (NgR1) and nogo
receptor 3 [NgR3 (Fisher et al., 2011; Dickendesher et al., 2012; Sharma et al., 2012)].
Interactions become even more complex as the CS-GAG domain of aggrecan is
composed of at least five different CS sulfation patterns, and evidence has shown that
these CS-GAGs have differing levels of inhibitory function (Gilbert et al., 2005).

In the

dynamic CNS environment, growth cones from distinct cell types could react differently
to aggrecan due to the presence of growth factors or activity based receptor expression.

Activity dependent alteration of aggrecan in CNS
. Aggrecan expression can be altered in response to epileptic seizures, and
CSPGs have been shown to be dysregulated in schizophrenic patients (McRae et al.,
2010; Berretta, 2013). In the visual cortex, aggrecan expression is regulated by
experience-dependent retinal activity. Numerous reports have indicated decreased
aggrecan expression at the perineuronal net (PNN), a structure shown to limit plasticity
after the closure of the critical period, in response to visual deprivation or dark-rearing
during early visual development (Sur et al, 1988; Lander et al., 1997). The effect of the
lost aggrecan enhances plasticity of neurons ensheathed in PNNs and prolongs the
critical period (Kind et al., 2013).
Since altered retinal activity can change the expression of aggrecan, I performed
experiments to gauge the effect of loss of retinal activity on aggrecan expression. The
math5-/- mutants contain a targeted deletion of the Math5 transcription factor, which is
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crucial for differentiation of retinal progenitor cells to RGCs. In the absence of Math5,
95% of RGCs are never formed (Wang et al., 2001). Through math5-/- cross-breeding
with the golli-tau-gfp mice, I was able to analyze the effects of silencing retinal input in
dLGN on CG innervation, and I was also able to determine how molecular expression of
aggrecan was altered in the absence of retinal instruction. The math5-/- mouse model
was particularly useful because I did not have to stress the mice with surgery, such as
encucleation, which could have triggered immune responses known to alter cellular
activities in the brain. Aggrecan degradation in both systems occurred in a mediolateral
pattern, thus establishing a gradient into which layer VI axons projected once aggrecanIR was low. As reported in the math5-/- mice, I observed accelerated CG fiber
innervation by 1-2 d compared to WT golli-tau-gfp mice, and I discovered that aggrecan
signal was degraded 1-2 earlier in the math5-/- mice.
These results prompted me to use qPCR to probe acan gene expression in
dLGN to see if the loss of retinal activity included a direct effect on the level of mRNA
transcription; unfortunately, the aggrecan transcription mirrored normal WT aggrecan
expression throughout development, and no significant difference in acan mRNA was
observed in age matched golli-tau-gfp and math5-/- dLGN samples. Microarray
analyses revealed that there was a family of adamts genes that were upregulated in
dLGN compared to vLGN at P3, and they continued to increase expression during the
development period. Nearly half of the ADAMTS family members, including ADAMTS1,
4, 5, 8, 9, 12, 15, 16, 18, and 19, have been characterized as functional aggrecanases
(Llamazares et al., 2007; Tortorella and Malfait, 2008).
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My transcriptional profile analyses provided more questions than answers, as is
often the case, and I had to take much care in designing a meaningful study due to
redundant functions of ADAMTS members. The ADAMTS family of enzymes has
selective activity on a plethora of extracellular proteoglycans including other members of
the lectican family (Stanton et al., 2011). Although there was no direct effect on
aggrecan expression, this information prompted a reformulation of my original
hypothesis to include the possibility that aggrecanases might be regulated by retinal
inputs instead of aggrecan. Although I originally thought aggrecan was directly affected
by retinal input, these results provide new and exciting avenues of research for
regulation of aggrecan in other areas of the brain.
Outside of the CNS, reports of aberrant aggrecan levels often include analysis of
ADAMTS/aggrecanases, but ADAMTS family member interactions with aggrecan in the
CNS remains unknown. Many of the previous reports on altered aggrecan expression
in the visual system do not mention aggrecanases as potential regulators of aggrecan.
During the course of my experimentation, I generated riboprobes for adamts4 which
show global CNS expression in the developing mouse brain, and probes directed
towards adamts15 indicate mRNA expression in medial thalamus, dLGN, and particular
subsets of cells in hippocampus (Data not shown). Therefore, I assert that
ADAMTS/aggrecanase expression and activity analyses could potentially be more
important for the regulation of critical periods and plasticity in CNS than previously
reports have suggested, and analyses of ADAMTS enzymes should be performed along
with aggrecan expression analyses.
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Regulation and function of ADAMTS in CNS
Most of the ADAMTS metalloproteinases were established as aggrecanases in
osteoarthritis studies outside of the CNS (Fosgang and Rogerson, 2010). Closely
related molecules from the ADAM (a disintegrin and metalloproteinase) family have
been identified as mediators of amyloid precursor proteins in Alzheimer’s disease, but
functional studies of ADAMTS family members in the CNS are in their infancy (Allinson
et al., 2003; Bernstein et al., 2003; Krstic et al., 2012). This lack of characterization
made it difficult to choose a particular ADAMTS/aggrecanase for my digestion
experiments. ADAMTS12 has not yet been well characterized in terms of CNS function,
like many of the ADAMTS members, but it has been shown to possess enzymatic
activities directed towards aggrecan (Llamazares et al., 2007). Recent publications had
shown some promising effects of ADAMTS4 in CNS, one of which reported ADAMTS4
mediated fuctional recovery in response to spinal cord injury (Tauchi et al., 2012).
Ultimately, I decided that this study must include ADAMTS4 because of its upregulation
in dLGN at the early postnatal ages, high aggrecanase activity, and availability.
Although my experiments focused on ADAMTS4 degradation of aggrecan, I
cannot discount the diversity of upregulated adamts mRNAs because they may not
have only redundant functions, but they could offer more insight into how ADAMTS
proteins work together during development to modify the ECM, in order to guide axons
or promote synaptogenesis. Previous reports, outside of the CNS, illustrated
coordination of ADAMTS5, ADAMTS9, and ADAMTS20 for the resorption of interdigital
webs. ADAMTS2, ADAMTS3, and ADAMTS14 have been shown to synergistically
degrade procollagens I and III (McCulloch et al., 2009; Le Goff et al., 2006).
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Cooperative functions of ADAMTS were also suggested though evolutionary analysis
that hypothesized that each ADAMTS might display some subfunctionalization and
specialization in certain tissues (Huxley-Jones et al., 2005).

Reports on the

assimilation of multiple ADAMTS proteinases to degrade one class of molecule provide
interesting prospects for future research, especially since I observed modest changes in
the regulation of many of the adamts mRNAs in the microarray comparison of the early
postnatal dLGN expression in golli-tau-gfp and math5-/-. Although I did not find as many
ADAMTS metalloproteinases to be altered significantly in the math5-/-, I did discover a
modest increase in many of the adamts family members that contain aggrecanase
activity, including adamts4, adamts8, adamts9, adamts15, and adamts16. Adamts12
mRNA levels were significantly upregulated, and there was also a significant 27%
increase amongst the entire family of adamts aggrecanases. Since the ADAMTS
enzymes have redundant functions, I believe that these increases provide ample
explanation for early aggrecan degradation in the math5-/- mice.
I extensively reported expression data in my analyses regarding ADAMTS, but I
must also recognize the possible effects of molecules that contribute to the activity
profiles of ADAMTS enzymes. Multiple regulators of ADAMTS metalloproteinase
activity have been documented. Tissue inhibitors of metalloproteinases (TIMPs) contain
4 members, but currently only TIMP1 and TIMP3 have identified roles in the inhibition of
ADAMTS metallproteinases (Murphy, 2011). Although neither was identified as
significantly altered in expression analyses, maintenance of TIMP levels combined with
modest increases in multiple ADAMTS proteins may contribute to greatly increased
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aggrecan degradation and accelerated timing of layer VI innervation in dLGN in the
math5-/- set of experiments.
Another possible level of regulation for ADAMTS could be achieved by a
completely different set of molecules from the TIMPS. ADAMTS are not immediately
active upon translation, and they must have metalloproteinase propeptides cleaved,
post-translationally, before they become enzymatically functional (Apte, 2009). In
addition to enzymatic digestion of the prodomain, ADAMTS4 activation occurs through
C-terminal truncation by MMP-17 [(matrix metalloproteinase-17) Gao et al., 2002; Gao
et al., 2004]. Aggrecanase activating and inhibiting factors can potentially be generated
by RGCs and dLGN neurons ; therefore, retinal input may alter activities of the
ADAMTS either directly through secretion of these factors or through induction of relay
neurons to produce and secrete them (Kay et al., 2011).

ADAMTS versus MMP degradation of aggrecan
Earlier in this manuscript, I briefly made the case for using rhADAMTS4 in my
experimental paradigms. In this section I will revisit this argument and compare
ADAMTS4 with other MMPs, instead of just focusing on other ADAMTS aggrecanases,
to solidify my justification for ADAMTS4 digestion of aggrecan in vivo.
MMP-3, -7, and -8 are all able to reverse the inhibition of neurite outgrowth due
to the presence of CSPGs, so they appear to have as much potential as ADAMTS4 to
degrade aggrecan if used in vivo. However, ADAMTS4 can cleave multiple fragments
of aggrecan, and it has been hypothesized that partial ADAMTS4 digestion of aggrecan
results in bioactive fragments that could produce neurite outgrowth, much like what has

112

been shown to occur when ADAMTS molecules cleave versican and brevican in vivo
(Sandy et al., 1991; McCulloch et al., 2009; Viapiano et al., 2008).
Another advantage of ADAMTS4 over MMP digestion in vivo is the inability of
ADAMTS4 to process laminin, which has been to shown to aid in the suppression of
CSPG inihibitory signaling (Cua et al., 2013; Snow et al., 1996). Furthermore, although
both ADAMTS4 and many MMPs cleave a multitude of differing target molecules within
the CNS,exogenous delivery of MMPs has been shown to cause neurotoxicity in vivo
due to a lack of localized, targeted protease activity (Xue et al., 2009; Gu et al., 2005;
Cua et al., 2013).
ADAMTS4 has a proteolysis-independent mechanism for inducing neurite
outgrowth, and it has been shown to be effective in allowing axon regeneration in
response to spinal cord injury (Hamel et al, 2008; Tauchi et al., 2012). Finally,
ADAMTS4 has been reported to be more effective than chABC in decreasing CSPG
inhibition, and chABC has been well characterized for its effectiveness in restoring axon
outgrowth in the spinal cord (Cua et al., 2013). Together these reports led me to believe
that ADAMTS4 could potentially be the most effective route for aggrecan degradation in
vivo.

Possible role for aggrecan in establishment of RF circuitry in dLGN
Much of this dissertation focused on the mechanisms that keep layer VI fibers out
of dLGN until RG axons begin to mature, but little has been discussed regarding how
aggrecan might affect RG synapse formation with relay neurons. Retinal activity
coordinates the establishment of proper eye-specific domains in the mouse dLGN, and
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the combination of repellent ephrin-A molecular guidance molecules and retinal activity
work together in the development of topographic maps in retino-recipient nuclei
(Feldheim et al., 1998; Torborg and Feller, 2005; Pfeiffenberger et al., 2006; Feller,
2009.) Furthermore, topographic mapping in SC and V1 are aligned through the
generation of normal spontaneous retinal waves (Triplett et al., 2009). These reports
support the notion that RF connections with relay neurons are very important in the
establishment of visual circuitry.
RGCs innervate the dLGN and form immature synapses at perinatal ages in the
mouse (Godement et al., 1984; Hong and Chen, 2011). During the first postnatal week,
when aggrecan is abundant in dLGN, 10-20 weak synapses from different RGCs
converge onto single relay neurons (Chen and Regehr. 2000). During this competition
phase, only the most suitable synapses will become functional, and the rest will be
retracted. Aggrecan could have multiple functions during this period. First, CS-GAGs
have been shown to sequester growth factors, masking them from binding receptors,
until a sheddase, like any of the ADAMTS aggrecanase enzymes, degrades the CS
domains and allows the growth cone to interact with the growth factors (Muir et al.,
1989; Sanes, 2003). As the axons compete for space, correctly formed RGC inputs
could prompt aggrecanse distribution to a specific location leading to the unmasking of
growth factors that promote synaptic differentiation and maturation.
RGCs express different guidance receptors which allow them to traverse to
different sides of the brain. Expression patterns of molecules, or combinations of
expression patterns, also lead to the divergent pathways when selective targeting
occurs in the CNS (Petros and Mason, 2008). As aggrecan is degraded from the
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medial edge to lateral border, RGC axons containing multiple CSPG receptors or
extremely sensitive receptors could defasciculate and move to areas where aggrecan
has been degraded. RGC axons that have no CSPG receptors or express high levels
of CAMs will form synaptic contacts in the areas where aggrecan levels are still robust.
This axon sorting model fits well with the competition phase because growth factors
would become more abundant to particular growth cones as sensitive fibers move to
more hospitable areas.
The assembly of neural circuits requires both specific temporal and spatial
organization. Mechanisms that drive the spatial control of axon guidance have been
well described, but the function and regulation of temporal controls of axon pathfinding
remain largely unknown. This manuscript details both a molecular mechanism for
temporal control of axons and its activity based regulation. My results suggest that the
timing of dLGN innervation by layer VI CG axons is regulated by aggrecan, and I
provide evidence for a signaling cascade by which transcriptional control of
ADAMTS/aggrecanases is mediated by RGC activity. Furthermore, these results
support the recent claim that retinal inputs instruct the timing of layer CG innervation in
dLGN (Seabrook et al., 2013). This study provides insight into the role of waiting
periods in the establishment of functional connectivity in CNS and reveals a novel
function for aggrecan in the developing nervous system.
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Appendix A
Probing for the Presence of GFAP-positive Astrocytes and Iba-1positive Microglia in Experimental Models
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Figure A1: Disassociated cortical cultures from embryonic tissue contain few
GFAP-positive astrocytes. (Left Frame) Low-magnification fluorescent image of GFAP
labeled astrocytes in P0 cortical culture. Note the network of astrocytes that fills most of
the field. (Middle and Right Frames)Higher-magnification fluorescent images of GFAP
labeled astrocytes from cortical culture obtained from E16 mice. Scale bars are 200
µm.
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Figure A2: GFAP positive astrocytes and Iba-1 positive microglia in bilateral injected
tissues. (Top Row) Fluorescent images indicating GFAP positive astrocytes, within
dLGN, one day post-neonatal injection of PNase (Left), chABC (Middle), or ADAMTS4
(Right). (Bottom Row) Fluorescent images showing Iba-1 positive microglial
proliferation in dLGN from mice treated with the same conditions as above. chABCinjected (Middle) tissues show the most Iba1 positive cells, while fewer microglia are
stained in PNase (Left) and ADAMTS4 (Right) treated animals. dLGN are encircled
with dots. Scale bar is 200µm.
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Figure A3: Comparison of GFAP positive astrocytes and Iba-1 positive microglia in gollitau-gfp and math5-/- mice. (Left Panel) GFAP immunostained sections in golli-tau-gfp
and math5-/- mice show very few astrocytes at P0 and at the time when CG axons begin
to invade dLGN. (Right Panel) Iba-1 positive microglia are sparsely expressed in dLGN
in both golli-tau-gfp and math5-/- mice at P0 and as CG fibers innervate dLGN. dLGN
are encircled with dots. Scale bar is 200µm.
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Appendix B
Retinal Innervation in acancmd Mice
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Figure B1: Retinal projections innervate dLGN in the absence of aggrecan. (Top panel)
Cat315 immunostained thalamus at E16 in WT and acancmd mice. Labeling of thalamus
does not occur using cat315 in the absence of functional aggrecan, thus showing
cat315 specificity. (Bottom Panel) Retinal labeling with DiI just after birth in WT and
acancmd mice show that retinal projections find their targets in the presence or absence
of aggrecan, but there appears to be some disorganization in axon fasciculation of
acancmd mice. dLGN are encircled with dots. Scale bars are 200µm.
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